Abstract
Pesticides are unique environmental contaminants that are specifically introduced into the environment to control pests, often by killing them. Although pesticide application serves many important purposes, including protection against crop loss and against vector-borne diseases, there are significant concerns over the potential toxic effects of pesticides to non-target organisms, including humans. In many cases, the molecular target of a pesticide is shared by non-target species, leading to the potential for untoward effects. Here, we review the history of pesticide usage and the neurotoxicity of selected classes of pesticides, including insecticides, herbicides, and fungicides, to humans and experimental animals. Specific emphasis is given to linkages between exposure to pesticides and risk of neurological disease and dysfunction in humans coupled with mechanistic findings in humans and animal models. Finally, we discuss emerging techniques and strategies to improve translation from animal models to humans.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Pesticides are substances or preparations that repel, destroy or control pests [1]. As a class of compounds, pesticides are, in practice, composed of many subclasses that are generally divided based on their target pests. Although not an exhaustive list, the primary classes include pesticides targeting insects (insecticides), weeds (herbicides), fungi and molds (fungicides), and rodents (rodenticides), all of which may have several subclasses of their own based upon chemical identity, physical state/application method (i.e., fumigants), and origin of derivation (i.e., biopesticides, botanicals, etc.). While clearly diverse, the common goal of pesticide application results in a unique situation of environmental exposure since pesticides are specifically put into the environment with the intent to damage an organism.
Historically, pesticide use dates to long before the Common Era, where elemental sulfur was among the first known chemicals used as a pesticide, a practice that continues today in grape vineyards [1]. Moving into the Common Era, toxic metals, primarily arsenic, were used as pesticides in a practice that persisted into the twentieth century. In the nineteenth century, during which chemistry made major strides, pesticides derived from natural products, including pyrethrum from chrysanthemums and rotenone from legumes, became common in their use. It was not until the late nineteenth and early twentieth centuries, however, that synthetic organic chemistry became the backbone of modern pesticides, starting with the identification of the insecticidal properties of organochlorine compounds [dichlorodiphenyltrichloroethane (DDT) and β-hexachlorocyclohexane (BHC)] in the 1930s, which had been first synthesized in the 1820–1870s. The identification of DDT as a cheap, broad-spectrum insecticide by Muller in 1939 led to the first demonstration of the ability of an insecticide to have a significant positive impact on human health; it showed outstanding efficacy in suppressing typhus, malaria, and other insect-borne diseases. At the same time, synthetic organic chemistry was also being used to develop nerve agents in parallel with insecticide development. Through this research, several nerve agents were identified, which also launched the introduction of the organophosphate insecticides that became the dominant insecticide class used in the twentieth century. During this same time, synthetic organic techniques were used to develop herbicides and fungicides, including 2,4-dichlorophenoxyacetic acid (2,4-D) and the dithiocarbamates, both of which are still heavily used. Today, worldwide pesticide usage approaches almost 8 billion pounds (3.6 billion kg) of active ingredient per year [2].
Pesticides have proven to be an essential tool in agriculture and public health [3]. The fact, however, is that molecular targets of pesticides are often shared between pest and non-target species, including humans. This is particularly true for the neurotoxic organochlorine, organophosphate, and pyrethroid pesticides. Similarly, pesticides that inhibit mitochondrial complex I are increasingly being used as miticides (mites) and acaricides (mites and ticks). Although herbicides and fungicides theoretically should not have shared targets with mammals, several have been demonstrated to affect the mammalian brain. This review will focus on major classes of pesticides that have been demonstrated to or are suspected of causing neurotoxicity based on clinical, epidemiological, and experimental studies. Finally, new and emerging technology for translating neurotoxic effects from the laboratory to humans will be discussed.
Organochlorine insecticides
Owing to their slow degradation, organochlorine pesticides are notoriously persistent chemicals in the tissues of mammals, especially those occupying higher trophic levels. Direct human exposure to organochlorine pesticides occurs through contaminated fruits, vegetables, grains, dairy products, and meats, as well as through agricultural settings [4]. In this section, we will discuss three organochlorine insecticides, DDT along with the cyclodienes, dieldrin and endosulfan, that have been linked to neurotoxicity and human neurodegenerative disease.
DDT
DDT was used extensively from the 1940s through 1972 in the United States (US) in agriculture as a broad-spectrum insecticide and for control of vector-borne diseases [5]. Although the use of DDT was banned in the US in 1972 over concerns regarding its environmental persistence and potential effects on wildlife, it was still used throughout the 1980s around the world for various reasons, e.g., mosquito control. Significant decreases in serum levels of DDT and its metabolite dichlorodiphenyldichloroethylene (DDE) levels have been observed in adults over the past three decades in the US. DDE, however, is still found in almost all serum samples from the centers for disease control and prevention’s cross-sectional National Health and Nutrition Examination Survey (NHANES) [6]. Current exposure sources likely include the import of food from countries where DDT is still used, or from legacy contamination of soil and waterways [7]. Indeed, the US Food and Drug Administration (FDA) reported that 15% of food samples surveyed contained measurable DDT levels in 2011. Internationally, DDT has been recommended by the World Health Organization (WHO) for malaria eradication, which has increased its usage in recent years.
DDT exerts its insecticidal activity by causing voltage-gated sodium channels (Nav) to remain open, leading to persistent depolarization and hyperactivity in the nervous system. DDT is only moderately toxic (rat oral LD50 = 113 mg/kg) [8] and oral administration of 3.5 or 35 mg DDT/day to humans for up to 18 months did not cause overt toxicity or neurotoxicity [9, 10]. However, the potential for chronic exposure to DDT has raised concerns about a variety of potential adverse health effects [11, 12]. Unfortunately, only a few human studies have explored the potential neurotoxicity of DDT. Two studies found that workers engaged in spraying DDT displayed cognitive dysfunction, although no measurements of DDT or DDE were available for either study [13, 14]. One small study reported that DDT was found more often in brains from patients with Alzheimer’s disease (AD; n = 7) compared to controls (n = 14) [15]. Most recently, a study using data from the NHANES population reported that serum DDE levels were associated with decreased cognitive function in elderly people in the US, suggesting that non-occupational exposures to DDT can also cause cognitive deficits [16]. Recently, Richardson and co-workers [17] reported that serum levels of DDE are approximately fourfold higher in AD patients, and this was associated with increased risk of AD diagnosis [odds ratio (OR) = 4.18]. Furthermore, high DDE levels and the presence of an apolipoprotein E (APOE) ε4 allele resulted in greater cognitive impairment when compared to those without an APOE ε4 allele. Concentrations of DDE and its parent compound DDT similar to those observed in highly exposed individuals in the general population of the US [10, 18, 19] also increased amyloid precursor protein levels in cultured neuronal cells.
Dieldrin
Based on a number of epidemiological and experimental studies, the organochlorine pesticide dieldrin is of particular concern, [20,21,22]. This insecticide was widely used throughout the US until the late 1980s when it was banned. It still persists heavily in the environment, particularly in soil sediments [23], due to its long half-life ranging between 141 and 592 days. Elevated levels of dieldrin persist in the serum of humans who have been previously exposed [22, 24]. For example, workers in India tied to the manufacture or use of dieldrin were found to have blood dieldrin levels up to 50 ng/ml [25]. Most importantly, high dieldrin levels have been detected in postmortem human Parkinson’s disease (PD) brains as compared to age-matched human control brains [15, 21, 26].
Exposure to dieldrin has a strong inhibitory effect on the central nervous system of insects such as flies and cockroaches [27] because of its effects on GABAA receptors.
Dieldrin-induced neurotoxicity has been reported in many in vitro studies using dopaminergic neuronal cells [21, 28]. Exposure of these cells to dieldrin promoted severe oxidative stress, mainly due to mitochondrial dysfunction [21, 28], and was accompanied by significant upregulation and activation of caspases, thereby leading to apoptosis [29, 30]. Caspase-3-dependent proteolytic cleavage of protein kinase C (PKCδ) plays a major role in dieldrin-induced dopaminergic neurotoxicity [21, 30]. Studies have also highlighted the ability of dieldrin to induce mitochondrial impairment and ubiquitin–proteasomal dysfunction [31, 32]. Overexpression of Bcl2 attenuated dieldrin-induced poly (ADP-ribose) polymerase cleavage and apoptosis, suggesting mitochondrial redox signaling is an upstream event of dieldrin-induced dopaminergic neurotoxicity [33].
Dieldrin-induced neurotoxicity has also been well studied using mouse models. Pivotal research showed that exposing perinatal mice to low doses of dieldrin (0.3, 1, or 3 mg/kg every 3 days) during their gestation and lactation period significantly altered dopaminergic neurochemistry and accentuated the severity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. This study also suggested that developing dopaminergic neurons might become more vulnerable later in life to chronic oxidative stress events [34]. A similar study demonstrated that another chlorinated cyclodiene, heptachlor, produced similar effects [35] and heptachlor epoxide levels have been associated with Lewy body pathology in postmortem PD brain [36]. Other studies highlighted the neurochemical deficits and oxidative damage, including in the nigrostriatal region, induced by chronic low-dose dieldrin exposure in animal models [20]. It was also reported that dieldrin induces epigenetic dysregulation through hyperacetylation of core histones in cell and mouse models of dieldrin neurotoxicity [37]. Collectively, these studies identify potential molecular mechanism by which dieldrin exposure may contribute to increased PD risk.
Endosulfan
Endosulfan is an organochlorine insecticide widely used in agriculture and forestry around the world. The US environmental protection agency (EPA) includes certain organochlorines including endosulfan, on its “extremely hazardous substances” list that was generated in 1987. However, despite the proposed ban in the US, endosulfan is still used worldwide [38]. About one billion tons of organochlorine pesticides, including endosulfan, have been manufactured and used commercially for insect control on fruits, vegetables, grains, cotton, and tea crops [21, 38]. Mounting evidence documents adverse effects of endosulfan on both the environment and non-target organisms due to its long persistence and high bioaccumulation in the tissues of animals and humans. It is known to be highly neurotoxic, causing both developmental neurotoxicity and chronic neurodegeneration in rodents [39, 40]. Furthermore, acute exposure in agricultural workers has been shown to lead to epilepsy, memory impairment, and hyperactivity disorders [40, 41].
In addition to inducing apoptotic cell death via mitochondrial dysfunction and oxidative stress [42], endosulfan treatments also promote inflammatory responses and glial activation in both cell culture and animal models [39, 43]. Furthermore, cell culture and animal models of PD reveal that dopaminergic neurons are more sensitive than other cell types to endosulfan-mediated neurotoxicity [44]. Animal studies further highlight the role of endosulfan in mediating PD-related neuropathological changes and neurochemical deficits, including dopamine depletion and increased levels of both normal and aggregated α-synuclein in mice [45]. Endosulfan-exposed mice also exhibits stunted central nervous system development with severe disruptions to synaptic trafficking events and synaptogenesis, which negatively modulates behavior, memory, and learning [46, 47]. A recent study [48] showed that rats gavaged with 2 mg/kg endosulfan for 6 days exhibited damaged brain mitochondria marked by significantly reduced levels of catalase, glutathione (GSH), and superoxide dismutase (SOD), and increased lipid peroxidation.
Organophosphate insecticides
Organophosphorus (OP) insecticides were developed in the 1930–1940s, but the first OP compound synthesis dates to the 1800s. Gerhard Schrader was the first to propose that organophosphate compounds could potentially be used as an insecticide. He continued to work on OPs at IG Farben in Germany, where he discovered several new insecticides, including parathion (E605), and accidentally the nerve agent tabun. Subsequent work by his group resulted in the synthesis of additional G-series nerve agents including sarin, soman, and cyclosarin, the formulas of which were taken over by the German government for large scale production [49]. In this section, we will review several OP insecticides, focusing on their chemistry, mechanism of action, and neurotoxicity in animal and human studies.
For both OP insecticides and nerve agents, the general chemical structure consists of a phosphorus atom bound to an oxygen or a sulfur atom [50]. The remaining bonds include a wide variety of groups that often consist of two alkoxy moieties and another moiety, which is often the “leaving group”. In the case of most insecticidal OPs, the phosphorus atom is bound to a sulfur atom that must be metabolically activated through a desulfuration reaction to form an oxon. This reaction is mediated through multiple cytochrome P450 enzymes primarily in the liver, but there is also evidence of target organ bioactivation (i.e., brain, lung, etc.). The desulfuration reaction proceeds through a phosphooxythiran intermediate that results in various ratios of oxon formation (via desulfuration), or another reaction generically termed diarylation which serves as a detoxication mechanism [51].
OP compounds exert neurotoxicity primarily through the inhibition of acetylcholinesterase (AChE). At the molecular level, the oxon moiety phosphorylates a serine hydroxyl found in the active site of AChE [52]. Once bound, the phosphorylated serine can be generated through spontaneous hydrolysis. This is a slow process with a rate that is generally determined by the nature of the leaving group, with less alkylated (i.e., dimethyl) compounds being hydrolyzed more rapidly than more alkylated (i.e., diethyl) compounds. In some cases, AChE can become “aged”, which represents a permanent inactivation caused by loss of one of the alkyl groups. Inhibition of AChE leads to a buildup of acetylcholine in the synapse, and hyperstimulation of cholinergic receptors in the central (primarily muscarinic receptors and some nicotinic) and peripheral nervous system (primarily nicotinic receptors and some muscarinic). This hyperstimulation leads to the classic signs of OP intoxication that is often clinically termed as SLUD syndrome (salivation, lacrimation, urination, and diarrhea), or the more encompassing DUMBBELS (diarrhea, urination, miosis/muscle weakness, bronchorrhea, bradycardia, emesis, lacrimation, salivation/sweating). Typically, these signs are observed in acute poisoning situations that result in over 70% inhibition of AChE [53]. If inhibition is severe and sustained, death may occur through depression of respiratory centers in the brainstem and paralysis of the diaphragm. Current countermeasures to acute OP intoxication include administration of atropine that blocks muscarinic receptors, oximes (i.e., 2-PAM) that assist with reactivation of AChE, and benzodiazepines (i.e., diazepam or midazolam) to control seizures.
Two additional syndromes have also been observed in some humans (~ 20%) poisoned with OP insecticides. The first is termed as the “intermediate syndrome,” which was first described in the 1980s. It typically begins days following a poisoning incident, and after the point when the patient appears to be recovering from acute cholinergic crisis [54]. This syndrome manifests as weakness of the respiratory muscles in the diaphragm, intercostals, and neck, along with weakness in the proximal limb muscles. At the present, there is no established relationship between specific OP pesticides and development of the syndrome. Clinical management involves maintaining respiratory function, and most patients exhibit full recovery. The second syndrome is termed as organophosphate-induced delayed polyneuropathy (OPIDN) [55]. OPIDN is relatively rare and occurs days to weeks after OP intoxication. The most famous example of OPIDN occurred during the Prohibition Era in the United States, when a large number of men (estimated in the tens of thousands) developed signs of OPIDN, including arm and leg weakness, following consumption of “Ginger Jake”, a patent medicine containing a large amount of alcohol. Subsequent investigation determined that the preparation was adulterated with tri-ortho cresyl phosphate (TOCP). The exposure caused axonal damage, particularly in the spinal cord, and led to the characteristic “jake leg” that presented with the toes touching the ground before the foot due to loss of motor control from muscles that moved the toes [56]. The molecular targets of OPIDN do not appear to be AChE, but rather a protein termed neuropathy target esterase (NTE) that involves an aging phenomenon similar to that observed with AChE [57]. Indeed, it is estimated that over 70% of NTE must be inhibited and aged for OPIDN to occur; however, not all inhibitors of NTE lead to OPIDN and structure activity relationships have revealed that only certain phosphates, phosphonates, and phosphoramidates can produce this effect [57]. Based on these findings, all OP insecticides must undergo screening for delayed neuropathy as part of regulatory approval and no pesticides that produce OPIDN are approved for use in the US.
Occupational exposures to OP insecticides at levels that do not result in the overt toxicities described above have become a major focus of research since they have the potential to result in long-term neurological impairment. Munoz-Quezada and co-workers recently reviewed the effects of chronic exposure to OP insecticides on neuropsychological function in farm workers [58]. Out of over 1000 articles, 33 met eligibility criteria for inclusion in the analysis, and 24 found significant associations between chronic occupational exposure to OP insecticides and reduced neuropsychological performance. The reduced performance spanned a variety of domains, including executive function, visuospatial ability, working and visual memory. Similarly, Ross and co-workers performed a meta-analysis of 14 studies related to low-level occupational exposure of OP insecticides [59]. The majority of these studies also found significant associations between OP exposure and impaired neurobehavioral function in the same domains mentioned previously. While there are numerous caveats to systematic reviews and meta-analyses, including the limited number of high-quality studies, the general consensus is that occupational exposure to OP insecticides leads to neurological impairment. Sanchez-Santed and colleagues have also reviewed potential links between OP exposure and overt neurodegeneration, which revealed a potential relationship between OP exposure and AD risk, mixed evidence for relationships to PD, and weak evidence for amyotrophic lateral sclerosis [60]. Although research in this area is limited, there have been tentative links established between OP exposure, particularly occupational exposures, and risk of AD [61, 62]. With regard to PD, the evidence for OP involvement is mainly negative, and positive associations are weak at best [60]. Similarly, there have been reported links between occupational OP exposures and amyotrophic lateral sclerosis, but these are, for the most part, inconsistent and weak [63]. Thus, occupational OP exposure appears to lead to disruption of neurological function, but much work remains to establish links with specific diseases.
With regard to non-occupational exposures, the 1990s represented a time of intensive investigation of potential developmental neurotoxicity following the National Academy of Science’s report entitled Pesticides in the Diets of Infants and Children (NAS, 1992). This report raised significant concerns regarding the potential for children to represent a uniquely susceptible population to OP neurotoxicity and identified dietary and non-dietary oral exposures as major routes of exposure. Specifically, the report identified a higher potential of exposure based on child-specific activities, the presence of critical periods of vulnerability in the developing nervous system, and that developing children do not have a full complement of enzymes involved in detoxication of OP insecticides [64]. To date, the majority of research on developmental neurotoxicity of OP insecticides is dominated by chlorpyrifos, which has been the most widely used of the OP insecticides [65]. Although much work continues in this area, the EPA effectively banned the household use of chlorpyrifos and most other OP insecticides in the early 2000s based on concerns over developmental neurotoxicity. Epidemiological studies have found that developmental exposure to chlorpyrifos is associated with a variety of neurodevelopmental endpoints in populations where there were higher exposures based on proximity to agriculture or extensive pest control spraying [66].
Mechanistically, it is unclear at this time whether all of the reported effects of developmental neurotoxicity resulting from OP insecticide exposure, and particularly chlorpyrifos, is the result of AChE inhibition or alternate targets [53]. In the past decade, additional targets of OP insecticides have been proposed, including axonal transport, axonal outgrowth, direct binding to acetylcholine receptors, disruption of neurotrophin levels, and, most recently, inhibition of other serine hydrolases such as fatty acid amide hydrolase [65]. The disruption of axonal transport has been ascribed to potential direct binding of OPs to tubulin and kinesin, which may provide a mechanistic link to observed changes in neurite outgrowth [67]. A recent study by Kanthasamy and colleagues reported that chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity in cell culture and animal models, suggesting potential non-cholinergic mechanisms of OP neurotoxicity in certain cell types and brain regions [68].
Pyrethroid insecticides
Pyrethroid insecticides were first used in the form of chrysanthemum crude extracts in the eighteenth century. Over 30 years ago, however, the first synthetic pyrethroids were introduced based on the structure of natural pyrethrins from chrysanthemum. Today, pyrethroid insecticides are one of the most widely used agricultural and household insecticides, accounting for about 25% of the worldwide insecticide market [69]. Further, pyrethroids are used extensively for public health and commercial concerns, including mosquito control following outbreaks of the West Nile, Ross River, and Dengue viruses, malaria, and for bed bug infestations [70, 71]. This increased usage has led to significant increases in the levels of pyrethroid residues in the environment worldwide [72]. In this section, we review the mechanism of action and studies of neurotoxicity in animals and humans.
Pyrethroids exert neurotoxicity primarily through modification of the kinetics of voltage-gated sodium channels (Nav), resulting in prolongation of the deactivation of sodium channels [73], similar to what is observed for DDT. Studies on pyrethroid neurotoxicity were initially focused on acute neurotoxicity and the identification of different syndromes produced by various pyrethroid insecticides. These studies revealed two major types of acute pyrethroid neurotoxicity [74]. The first, designated the T syndrome, showed dominant signs of neurotoxicity that included tremor, twitching, coma, and death. With the discovery of deltamethrin, the first pyrethroid containing a cyano group, a different acute syndrome was observed that presented as salivation, jerking leg movements, and choreoathetosis. This was termed as the CS syndrome to reflect choreoathetosis and salivation. Subsequent work by Casida’s laboratory proposed an alternative nomenclature to describe pyrethroid-induced neurotoxicity that included symptoms of intoxication, chemical structure, and electrophysiological actions in insects. Casida’s group labeled them Type I or Type II pyrethroids and the acute toxic effects were similar to those described for T syndrome and CS syndrome, respectively [75]. It should be noted that this classification is not perfect, and different pyrethroids can display aspects of both Type I and Type II syndromes. From a mechanistic standpoint, Type I compounds generally prolong action potentials for a shorter period of time compared with the Type II, which results in repetitive firing of the action potential and a depolarizing block, respectively [74].
More recently, research has been focused on the potential neurotoxicity of longer term, but lower level pyrethroid exposures that do not result in overt intoxication in humans and animals. Although exposure of the general population to pyrethroids is often thought to be low, humans lack serum carboxylesterases [76], a primary mechanism of pyrethroid detoxication through hydrolysis. This could potentially lead to humans having a reduced capacity to metabolize pyrethroids. Data from a recent physiologically based pharmacokinetic (PBPK) study predicted that exposure to the Type II pyrethroid deltamethrin was predicted to result in a twofold greater peak brain concentration in humans compared to rats [77]. Neurological effects, including cognitive impairment, have been observed following pyrethroid exposure of pesticide applicators and their families [78, 79]. Further, recent data demonstrate neurotoxic effects following pyrethroid exposure, particularly in sensitive populations such as children [80, 81].
Age-related sensitivity to pyrethroids has been a focus of intense investigation based on early findings that younger animals were much more sensitive to higher levels of pyrethroids [82]. This led to concerns that exposure of pregnant women and children to these compounds may lead to neurotoxic effects in children during development due to decreased metabolic capacity [83, 84]. More recently, PBPK modeling techniques have been employed to address age-related differences of pyrethroid metabolism [85, 86]. These support the previously identified differences in toxic susceptibility. Further, incomplete development of the blood–brain barrier (BBB) at early ages may lead to enhanced brain accumulation [87]. Experimentally, pyrethroid exposure in rats or mice during development has been reported to have a broad range of potentially neurotoxic effects on various neurotransmitter systems, the BBB and neurobehavior [69].
Adult exposure of rodents to pyrethroids at doses that do not result in the classic T or CS syndrome has been found to elicit a variety of neurotoxic effects [74]. Wolansky and Harrill [88] reviewed studies on 20 pyrethroids as they related to adult neurobehavioral toxicity following acute exposure and found that Type I pyrethroids generally increased acoustic-evoked startle response amplitude. This was in contrast to Type II pyrethroids that decreased this response. Other studies demonstrated the ability of pyrethroids, particularly deltamethrin, to cause apoptosis through the endoplasmic reticulum (ER) stress pathway in cultured neuronal cells and animals [89,90,91]. Repeated exposure to other Type II pyrethroids has been demonstrated to cause dopaminergic neurodegeneration and alter mitochondrial function in vitro and in vivo [92]. More recently, repeated pyrethroid exposure was linked to direct effects on glial cells and to cause neuroinflammation in vivo [93,94,95] and anti-inflammatory treatment reduced cypermethrin-induced dopaminergic neurodegeneration [96]. This may be particularly relevant to human neurotoxicity, as postmortem analysis of Parkinson’s disease brain revealed enhanced microglial expression of Nav 1.6, which was targeted by pyrethroids [97]. Pyrethroid exposure, primarily in the form of permethrin, alone or in combination with exposure to other neurotoxicants or prophylactic treatments (i.e., pyridostigmine bromide) has also been linked to Gulf War illness, perhaps through a pro-inflammatory mechanism [98].
Mitochondrial Complex I inhibitors as insecticides
Pesticides that inhibit mitochondrial Complex I are increasingly being used as miticides and acaricides. Mammalian mitochondrial Complex I is a large membrane-bound enzyme consisting of 45 protein subunits that oxidizes matrix NADH and transfers electrons to the lipid-soluble carrier ubiquinone. Complex I also translocates protons across the inner mitochondrial membrane against a proton motive force, thus establishing a proton gradient that drives ATP synthesis and leads to the generation of a mitochondrial electrochemical membrane potential. Neurons are extremely sensitive to mitochondrial dysfunction due to their considerable energy demand, and for this reason, defects in Complex I are expected to contribute to several human neurological disorders. Indeed, the inhibition of Complex I has become a widely accepted pathway contributing to the pathogenesis of PD. Loss of Complex I catalytic activity within the mitochondrial electron transport chain has been detected in multiple brain and peripheral tissues from individuals with sporadic PD, including the substantia nigra pars compacta (SNpc), frontal cortex, skeletal muscle, lymphocytes, and platelets, suggesting a systemic Complex I defect in PD [99, 100]. Schapira et al. [101] reported a distinct reduction of 15–30% in Complex I activity in non-familial, sporadic PD cases. This impaired Complex I activity in PD brains may be associated with increased oxidation of the catalytic subunits and disrupted assembly of Complex I subunits [102].
Further evidence for the involvement of mitochondrial Complex I inhibition in PD emerged with the discovery of the synthetic heroin analog MPTP in 1982 when several drug users in California developed subacute onset of severe Parkinsonism [103]. MPTP is a lipophilic neurotoxin that can easily cross the blood–brain barrier and be metabolized to the active toxin 1-methyl-4-phenylpyridinium (MPP+). MPP+ is a Complex I inhibitor that can be selectively taken up by the dopamine neurons [104]. In addition to MPTP, a variety of mitochondrial Complex I inhibitors, including the pesticide rotenone, induce Parkinsonism in rodents and non-human primates, providing important insight into the role of Complex I deficiency in PD pathogenesis. Mechanistically, rotenone and pyridaben are potent inhibitors of mitochondrial Complex I activity, and thereby they reduce oxygen consumption and bioenergy deficits resulting in structural damage to mitochondria. In this section, we focus on two Complex I inhibitor pesticides, rotenone and pyridaben. Current knowledge regarding their neurotoxicity and relation to PD etiopathogenesis will also be summarized.
Rotenone
Among the neurotoxic pesticides associated with PD, rotenone is a well characterized, highly selective inhibitor of mitochondrial Complex I that occurs naturally in the roots of several plant species [105]. Rotenone is frequently used worldwide to control fish populations, thus raising the potential for environmental exposure in humans and the need to address its toxicological and pathological profile [106, 107]. Rotenone is highly hydrophobic and readily crosses the cell membrane without the aid of specific transport mechanisms (unlike MPP+). An adverse outcome pathway (AOP) was recently constructed to highlight mitochondrial Complex I inhibition as the molecular initiating event for plausibly linking rotenone exposure to the risk of developing PD based on mitochondrial dysfunction, impaired proteostasis, neuroinflammation and the degeneration of dopaminergic neurons as the key events indicative of disease onset [108].
Although rotenone has a relatively short half-life in the environment and limited commercial use, epidemiological studies using rigorous case-control data over several decades of reported PD cases have linked chronic, environmental rotenone exposure to a higher risk of developing PD in specific populations [107, 109]. Another noteworthy study was the recent French AGRICAN cohort study, which after controlling for crop type, livestock, sex, age, education, smoking status, and alcohol consumption, logistically regressed PD risk against the duration of pesticide exposure. The results suggest that the risk of PD increases in farmers exposed to certain pesticides including rotenone [110].
With the link established between Complex I inhibition and PD, rotenone has gained significant attention as both a potentially causative agent of and possible modeling tool for PD.
Although mixed reports on the extent of the pathology induced by rotenone have been produced, there is now compelling experimental evidence showing that chronic treatment of rats with rotenone is capable of inducing many key pathological features and neurochemical hallmarks of PD [106, 111, 112]. The most prominent study, by Betarbet and colleagues, used a chronic, systemic infusion protocol via a jugular vein cannula attached to an osmotic minipump, to show that systemic inhibition of Complex I by rotenone caused selective degeneration of dopaminergic neurons and terminals in the SNpc and striatum, respectively, accumulation of ubiquitin- and α-synuclein-positive cytoplasmic inclusions, as well as the development of motor and postural deficits characteristic of PD [106]. So far, various routes of administration of rotenone have been used to establish animal models of PD, and the most common delivery regimen to induce PD symptoms in rats is through a chronic, systemic administration of the compound. Subcutaneous, intravenous, and intraperitoneal injections of rotenone have all been shown to induce chronic progressive degeneration of the nigrostriatal pathway and α-synuclein pathology [113]. The apparent disadvantage, however, of systemic administration of rotenone is the substantial variability in neuropathological changes and high mortality of animal populations. It was also reported that the deleterious effects induced by chronic systemic rotenone treatment are not specific to the dopaminergic system [114], suggesting that rotenone-induced neurodegeneration seen in experimental rats more closely resembles an atypical Parkinsonism rather than idiopathic PD itself.
The neurotoxic mechanisms underlying rotenone-induced Parkinsonism are thought to involve the inhibition of oxidative phosphorylation, heightened oxidative damage, interruption of the mitochondrial electron transport chain, and Ca2+-mediated cellular excitotoxicity [111, 112]. Rotenone treatment produces abundant oxidative damage to cellular macromolecules such as proteins, lipids, and nucleic acids [115]. A chronic, 48-h exposure of PC12 cells (derived from a pheochromocytoma from rat adrenal medulla) to rotenone leads to intracellular dopamine oxidation-mediated cell death [116]. In in vitro models, rotenone exposure potently disrupts autophagy and promotes α-synuclein aggregation [117, 118]. As a Complex I inhibitor, rotenone can dysregulate multiple mitochondrial functions that are essential for mitochondrial maintenance. For example, rotenone-treated neuronal cells exhibit mitophagy involving the externalization of the mitochondrial lipid cardiolipin (LC) to the mitochondrial surface and the subsequent recruitment of the autophagic machinery through an interaction between cardiolipin and LC3 [119]. Mitophagy is a specialized autophagic process that selectively degrades damaged mitochondria. A similar study by the same group reinforced the importance of the cardiolipin–LC3 interaction as a signal for rotenone-induced mitophagy in SH-SY5Y cells, a neuroblastoma human line [120]. Similar to MPTP, rotenone neurotoxicity may include a neuroinflammatory component. Rotenone has been shown to induce microglial activation in BV2 microglial cell line leading to production of inducible nitric oxide synthase (iNOS) and other pro-inflammatory factors like TNFα and IL-1β [121]. N-acetylcysteine, a reactive oxygen species (ROS) scavenger, was shown to reduce this rotenone-induced inflammation by reducing NFκB and p38 MAPK activation [121]. Rotenone was also shown to directly interact with membrane-bound NADPH oxidase 2 (NOX2), the catalytic subunit of NOX2 enzyme complex, thereby playing an important role in SOD and ROS generation [122]. Recently, the Kanthasamy laboratory demonstrated that rotenone exposure leads to NLRP3 inflammasome activation in microglial cells in cell culture and animal models [123]. It was further shown that mitochondrial SOD formation plays an important role in rotenone-induced inflammasome activation [123].
Pyridaben
Pyridaben is a commonly used acaricide in vineyards and commercial greenhouses [124]. Chemically classified as a pyridazinone, pyridaben has also been shown to function as a mitochondrial Complex I inhibitor, according to the Insecticide Resistance Action Committee (IRAC), similar to rotenone. Moreover, the Washington State Department of Agriculture recently documented neurological, ocular, and gastrointestinal symptoms in farm workers poisoned by an off-target exposure to pyridaben [125].
Like rotenone, pyridaben 1) can significantly inhibit mitochondrial respiration, as demonstrated in Caenorhabditis elegans (C. elegans) acutely exposed for just 1 h to either 50 μM rotenone or 25 μM pyridaben [124], and 2) is highly lipophilic and can thus easily cross the BBB [126]. Despite the link between Complex I dysfunction and PD, the epidemiological evidence linking pyridaben exposure to PD risk is currently lacking. Recent research has demonstrated that exposure to low, nano- or micro-molar concentrations of pyridaben induces significant neurotoxicity in cultured neuronal cells and organotypic midbrain slices [127, 128]. In fact, pyridaben proved to have higher toxicity in SK-N-MC human neuroblastoma cells than did rotenone [128]. In another study, Gollamudi et al. [129] found a strong correlation between pyridaben exposure and both dopaminergic neuronal loss and increased α-synuclein immunoreactivity in pyridaben-treated C57BL mice. The authors also performed an RNA sequencing analysis that revealed gene expression patterns bearing significant correspondence to pathways that are well known in human PD cases. Besides mitochondrial Complex I impairment, thus far only a few putative pathogenic mechanisms have been proposed to explain pyridaben-induced neurotoxicity, including oxidative stress and ubiquitin–proteasome system (UPS) dysfunction [130, 131], which are highly interrelated molecular pathways that could synergistically culminate in neuronal death [132].
Neurotoxicity of herbicides
Historically, assessing the general or neurotoxic mechanisms of herbicides in non-target organisms, such as humans or other mammals, has not been a high priority in pesticide research. As mentioned previously, the primary reason is that most herbicides exert their action in plants via pathways not found in mammals. For example, the most widely applied herbicide in the world uses glyphosate as its active ingredient [133]. Glyphosate’s herbicidal mechanism of action is through its ability to inhibit the shikimic acid pathway, which is responsible for the synthesis of aromatic amino acids (e.g., phenylalanine, tyrosine, and tryptophan) in plants. Since this pathway does not exist in mammals, the potential toxicity associated with chronic glyphosate exposure was largely ignored until the early 2000s [134]. Similarly, atrazine, the second most applied herbicide in the US, kills plants by inhibiting the photosystem II complex (PS II) protein D2 [135]. Furthermore, designing toxicity studies is complicated by the fact that herbicides, and pesticides in general, are a mixture of one or more active ingredients with multiple adjuvants that are included in the commercial formulation to increase the potency and/or efficacy of the active ingredient. The exact nature of these adjuvants can also vary by country and manufacturer. Notably, the chemicals used as adjuvants are generally not disclosed due to their proprietary nature. While these issues are not unique to any of the top herbicides in use today, further research is required to address the gaps in our knowledge related to mechanisms of neurotoxicity and neuropathology in humans, and to identify the nature of the toxic components in commercial formulations. Addressing this latter issue will also provide information that could lead to herbicide formulations that have decreased neurotoxicity in humans and other mammals.
Glyphosate-containing herbicides
Glyphosate-containing herbicides (e.g., Roundup, Touchdown) are by far the most widely used pesticides in the world. Between 2012 and 2015, the amount of these herbicides applied each year was over four times greater than that of the second-place pesticide [64, 92]. For many years, the active ingredient, glyphosate, was largely considered relatively non-toxic due to its high oral LD50 in both rats (5.6 g/kg) and mice (10 g/kg) in acute studies [136]. This low toxicity is consistent with recent studies demonstrating that commercial formulations are generally more toxic than glyphosate alone [137, 138]. Studies evaluating the neurotoxicity of glyphosate (or the commercial formulation) are much less well documented or emphasized. While some research suggests that glyphosate inhibits AChE [139], the IC50 in human serum was calculated to be 714 mM [140], which is much higher than blood concentrations associated with indirect exposures (< 0.05 mM) or acute poisoning (0.05–5.0 mM) [139]. As such, this seems unlikely to be a mechanism of neurotoxicity. In terms of neuropathology, dopaminergic and γ-aminobutyric acidergic neurons preferentially undergo neurodegeneration in C. elegans treated with commercial glyphosate formulations at concentrations used by pesticide applicators [141, 142]. This neurodegeneration was attributed to mitochondrial inhibition and increased oxidative stress [143]. Other studies demonstrate that zebrafish exposed to glyphosate formulations show abnormal brain development [144, 145], which may be attributable to glutamate excitotoxicity [146, 147] observed in developing rats exposed to glyphosate. More recently, rats treated with a commercial formulation showed increased anxiety and depression that correlated with changes in gut microbiota number and diversity [148]. Since many bacteria also rely on the shikimic acid pathway to produce cyclic amino acids, inhibition of this pathway by glyphosate is hypothesized to decrease tryptophan catabolism. This decrease is potentially important since tryptophan is the precursor for serotonin, which plays an important role in both anxiety and depression. Taken together, these recent studies strongly support further research into the potential neurotoxic effects of glyphosate-based herbicides.
Paraquat-containing herbicides
Data regarding paraquat’s neurotoxicity are probably the most conclusive of all herbicides. Paraquat exposure has been linked to an increased risk for PD [107], and has been used in animals to model aspects of PD pathology, including dopamine neuron loss and synuclein aggregation through its induction of oxidative stress and neuroinflammation [149,150,151,152]. Exposure to paraquat also promotes tyrosine phosphorylation of parkin in SH-SY5Y cells [153]. This post-translational modification of parkin, which inhibits the protein’s function, facilitates disease progression. Paraquat exposure has been shown to induce hyperacetylation in cell models of Parkinson’s disease, suggesting that prolonged exposure of this pesticide may promote epigenetic reprograming [154]. More recently, data from induced pluripotent human stem cells treated with paraquat showed increases in the proinflammatory cytokine, interleukin-6 (IL-6). This cytokine is also part of the senescence-associated secretory phenotype in both astrocytes and fibroblasts [155]. Additionally, conditioned media from paraquat-treated astrocytes induced dopaminergic cell death. Paraquat incubation also resulted in an increase in secretogranin II (SCG2) production in astrocytes [156], which is associated with large, dense core vesicles that co-localized with IL-6. Taken together, these data suggest that exposure to paraquat, in addition to increasing oxidative stress, may also increase the release of IL-6 to promote neuroinflammation. Future studies may provide additional insight as to how paraquat and other herbicides modulate inflammatory pathways and initiate processes associated with neurodegeneration.
Neurotoxicity of fungicides
Early fungus control (1700s) was achieved by adding arsenic to fields where important crops were grown. Later (1800s), lime (calcium carbonate) or dolomite (magnesium calcium carbonate) was used, followed by the application of copper sulfate. Eventually, methylmercury (1900s) was applied to plants and seeds to prevent fungal outbreaks in seed stocks intended for use in breads and cereals [157]. Using heavy metals to protect food crops, however, came with the risk of poisoning human populations. Perhaps one of the most infamous occurrences of human toxicity from fungicide exposure happened in Iraq in the early 1970s [158,159,160]. Grain treated with methylmercury and intended for planting was instead consumed by entire communities. This resulted in methylmercury intoxication in hundreds of people, and the death of over 400. Despite this, heavy metals are still among the most widely used active ingredients in fungicides in the US. Many fungicides exert their effects via multimodal mechanisms, meaning that they cause fungal death through multiple pathways. Some of the more common pathways involve the production of oxidative stress by increasing ROS and depleting available antioxidant enzymes (e.g., SOD, catalase, glutathione-S-transferase) or molecules (i.e., GSH). In other cases, inhibition of mitochondria results in fungal death. Finally, these pesticides may exert their fungicidal action through the chelation of essential metals in the organism [161]. Regrettably, many of these pathways, enzymes, and molecules are also found in several species of mammals, including humans. Furthermore, all of these targets are found in the brain. It is, therefore, not surprising that accidental, chronic, or indirect exposure to fungicides may lead to neurotoxicity.
Manganese ethylene-bis-dithiocarbamate (EBDC)-containing fungicides
With the exception of manganese (Mn)/zinc (Zn)-EBDC, no systematic neurotoxicity has been associated with, or reported for, the top four most widely used commercial pesticides in the US. While Mn/Zn-EBDC (mancozeb) is not as well studied as Mn-EBDC (maneb), the latter was voluntarily withdrawn from the US market in 2010. As a result of this removal, Mn/Zn-EBDC is now the second most common commercial fungicide [2]. Studies in humans [162], human-derived cell culture [163], and non-target animals [164] exposed to Mn/Zn-EBDC have shown increased blood, cell, and tissue Mn levels, respectively. These higher Mn concentrations, along with measurable amounts of ethylene thiourea (an EBDC metabolite), in children raised near banana plantations in Costa Rica are correlated with adverse neurobehavioral outcomes [162]. It is unclear whether Mn/Zn-EBDC has the same propensity to affect dopaminergic neurons as maneb [165] or increase a person’s risk for PD [166, 167]. Studies in C. elegans, however, have shown that the dopaminergic system is one of the targets following either acute or chronic exposures to this fungicide [142, 168]. Furthermore, the toxicity appears to be blocked when worms are pretreated with a dopamine transporter antagonist [169], suggesting it may enter dopamine neurons via this presynaptic transporter. Since the neurotoxic mechanism of action of Mn/Zn-EBDC appears to involve oxidative stress [170] and mitochondrial inhibition [171], it is not unreasonable to hypothesize that neurons, among other cell types, would be vulnerable to Mn/Zn-EBDC exposure. It is currently unknown, however, how this fungicide might cross the blood–brain barrier and enter the brain. Additional research regarding the associated neurotoxicity should not only provide insight into the toxic mechanisms of organic metal fungicides in general, but also afford opportunities to better understand how metal complexes are transported to, and deposited in, specific regions of the brain.
Emerging techniques for translational research in neurotoxicity
The previous section has summarized historical and current knowledge on the relationship between pesticide exposure and neurotoxicity. However, there remains a significant challenge in translating mechanistic work in cells and animals to human populations. Further, epidemiological studies primarily reveal associations between exposure and neurotoxic outcomes, most of which are behavioral in nature and lack mechanistic or neuropathological insight. Finally, the large number of potentially neurotoxic compounds and mixtures of compounds that may not have been adequately studied requires a robust and high-throughput approach. Thus, there is a significant need to incorporate new and emerging techniques and models to aid in translational research.
In recent years, the effects of pesticide exposure on brain function and structural damage or degeneration have been investigated using a number of in vivo imaging techniques. For example, magnetic resonance imaging (MRI) studies demonstrated that glufosinate ammonium, the active component of many herbicides, causes dose-dependent structural alteration in the hippocampus and somatosensorial cortex of chronically exposed mice [172]. More recently, MRI has been used to demonstrate the correlation between OP-induced brain damage (cortical edema and brain metabolic dysfunction) and clinical outcomes (behavior and pathology), as well as to study the effectiveness of potential antidotes [173]. Similarly, MRI has also been used to show that repeated OP exposure at levels that do not induce acute toxicity and appear unrelated to inhibition of AChE can induce persistent inhibition of axonal transport [174]. As MRI allows visualization of effects in the intact living animal, it represents a useful tool to link functional and structural deficits in the brain to both in vivo neurobehavioral effects and in vitro mechanisms. Given the possibility to also apply these imaging techniques in human patients, and even in epidemiological studies, these techniques hold great promise for improved diagnosis, biomarker identification, and investigation of neuroprotective treatments.
From a mechanistic standpoint, a relatively newer development that may speed up translational pesticide research is multi-well microelectrode array (mwMEA) recordings. MEAs typically consist of an electrode array containing 16–64 electrodes and allows for non-invasive recordings of neuronal activity in an in vitro neuronal network [175]. Neuronal networks grown on MEAs develop spontaneous electrical activity over time and are responsive to neurotransmitters and pharmacological agents comparable to in vivo neurons [176, 177]. While traditional single-well MEA systems have a relatively low throughput, the recent development of mwMEAs with 12-, 48-, or 96-wells has increased the throughput and its use in neurotoxicity testing considerably. MEA recordings are typically performed using heterogeneous neuronal networks, consisting of multiple types of neurons and supporting cells that span a wide range of potential targets (e.g., neurotransmitter receptors, ion channels, intracellular signaling pathways) that can all contribute to modulation of spontaneous neuronal activity.
Just over 10 years ago, these MEA recordings were used to investigate the effects of the pyrethroid insecticides deltamethrin and permethrin on neuronal activity in vitro in hippocampal cultures [178] and cortical cultures [179]. Both compounds reduced neuronal activity in a concentration-dependent manner, with the Type II pyrethroid deltamethrin being more potent than the Type I pyrethroid permethrin. Since then, these results have been reproduced by multiple laboratories [180, 181], highlighting the robustness of this innovative technique. In recent years, a large number of other types of pesticides have been investigated using MEA recordings. Other pyrethroids, like bifenthrin, cyhalothrin, cypermethrin, β-cyfluthrin, and esfenvalerate [180, 182, 183] as well as the carbamate carbaryl [182] and the OP chlorpyrifos/chlorpyrifos-oxon [184] have also been shown to concentration-dependently decrease neuronal activity. Interestingly, the herbicide glufosinate [185] and the organochlorines insecticides lindane [184, 186] and endosulfan [182] exert biphasic effects on neuronal activity. Neuronal activity is increased at low concentrations, due to N-methyl-d-aspartate subtype glutamate receptor agonism and γ-aminobutyric acid receptor antagonism, respectively. Neuronal activity is inhibited at higher concentrations, likely due to less-specific effects such as inhibition of voltage-gated calcium channels [187]. Collectively, this work provides important insight into the direct effects of pesticides on neuronal function that was previously only performed in isolated single neurons.
Due to their non-invasive nature, MEA recordings have recently also been used to investigate the effects of chronic exposure to different pesticides during neurodevelopment of the in vitro network [182]. The observed effects are largely comparable to acute exposure for chlorpyrifos, α-cypermethrin, and endosulfan, whereas chlorpyrifos oxon and carbaryl inhibited neuronal activity only during acute exposure suggesting some sort of adaptive capacity in the developing neuronal network. As mwMEA recordings have a considerable throughput, they are also suitable for assessing mixture effects. These mixture assessments have been mainly limited to binary [188] and more complex [183] mixtures of pyrethroids. These studies indicate that pyrethroid mixtures in vitro cause dose-additive effects on spontaneous neuronal network activity, consistent with in vivo assessments of pyrethroid mixtures.
As mentioned above, assessment of mixture effects is still often performed using (binary) mixtures of similarly acting pesticides. For example, additive effects of pyrethroid mixtures on increased sodium influx through Nav have previously been shown in cortical neurons [189]. Similarly, mixtures of OP and/or carbamate insecticides generally show additive or even synergistic effects with respect to their presumed primary mode of action, i.e., inhibition of AChE [190, 191]. To better bridge the gap between in vitro and in vivo studies with the human exposure situation, however, experiments using complex mixtures that more closely resemble real life exposures are required. Additionally, such experiments should not focus on the distinct separate modes of action, but may need to take into account integrated endpoints, e.g., neurobehavior and brain imaging (in vivo) or neuronal activity measurements using MEA recordings (in vitro). Several more recent experiments, using complex mixtures of pesticides with different primary modes of action, have shown synergistic, agonistic, and antagonistic effects, depending on the type of endpoints, species, and sex studied [192]. The number of potential mixture combinations is immense, and the resulting effects can range from additive (most common for same mode of action) to antagonistic and synergistic (in particular for divergent modes of action that are upstream of a more integrated endpoint). Although essential to bridge the gap between in vivo and in vitro experimental research and the human exposure situation as studied in epidemiology, mixture toxicology will remain a huge challenge for future research.
Obviously, behavioral assessment in the in vivo situation provides a strong integrated endpoint for effects assessment of (mixtures of) pesticides. The major drawback of low-throughput animal studies may be largely circumvented using alternative species, such as Drosophila melanogaster or C. elegans. As Drosophila is an important target species, it has been used mainly to determine the effectiveness of pesticides. The nematode C. elegans, on the other hand, has been used for over 10 years to investigate acute behavioral toxicity of pesticides. C. elegans has become a well established model lab organism as it has a short life cycle (allowing for more throughput), is inexpensive, has a high degree of evolutionary conservation with mammals, and its nervous system connectivity has been completely mapped. The possibility for automated assessment of effects in highly integrated endpoints, such as locomotion and feeding behavior, further increases its value as model for studying mammalian (developmental) neurotoxicity of pesticides [193, 194]. As potential target species, however, translatability to human neurotoxicity might be challenging, particularly for pesticides with high selectivity for arthropoda and nematoda.
The use of zebrafish, particularly in the embryo or larval stage, may bypass some of the translational challenges while maintaining throughput. Consequently, zebrafish has emerged over the last 15 years as an appreciated and complementary vertebrate model to study pesticide-induced (developmental) neurotoxicity [195]. Zebrafish have been extensively used to investigate effects of pesticides on parameters that are indicative for gross neurotoxicity. Likewise, zebrafish have been used as an experimental model to assess pyrethroid-induced developmental neurotoxicity [196,197,198]. Similar to observations in mammals, pyrethroid exposure in zebrafish results in behavioral disruption, including hyperactivity, particularly for deltamethrin [199].
Exposure to chlorpyrifos in a concentration-dependent manner increases the frequency and total duration of spontaneous tail coilings at 24–26 h post-fertilization (hpf), whereas swimming activity is decreased at 96 hpf, highlighting that effects may differ with developmental stage [200]. Additional methods exist to increase mechanistic insight, including neurotransmitter profiling, which has been used to demonstrate that levels of acetylcholine in zebrafish decrease following the exposure to the neonicotinoid imidacloprid and several carbamate and OP insecticides [201]. In particular, the recent use of fluorescent transgenic zebrafish lines may allow for further assessing of specific effects on distinct targets or pathways, such as insecticide-induced motor neuron degeneration [202].
As outlined above, current hazard characterization and risk assessment of pesticides still heavily relies on ethically debated, time- and resource-intensive animal experiments, which are not always fully predictive for human adverse health effects. At the same time, most in vitro test strategies are not sophisticated enough to be sufficiently predictive to replace animal experiments. This is at least partly due to the animal origin of many currently used in vitro models. With the development of human neural stem cell (NSC) lines and human-induced pluripotent stem cell (hiPSC)-derived neuronal cultures, this may now be feasible. These cell cultures can be maintained for weeks or months and can be grown as pure neuronal cultures or as co-cultures with astrocytes or other glial cells. As these models mature over time to form a complex network of spontaneously active cells [203, 204], it allows for assessing both developmental and acute neurotoxicity testing in vitro. Using mwMEA recordings, it was shown that the insecticide and γ-aminobutyric acidA receptor antagonist endosulfan, which evokes hyperexcitation in vivo, increases neuronal activity of commercially available hiPSC-derived pure neuronal cultures [204] and neuronal co-cultures with astrocytes [205].
Using a human stem cell-based model, it was shown that developmental chlorpyrifos exposure reduced the expression of several neural differentiation marker genes, decreased intracellular ATP levels, and induced mitochondrial fragmentation [206]. Importantly, co-culturing hiPSC-derived neuronal cultures with astrocytes, which have high expression of cytochrome P450 enzymes, allows for inclusion of biotransformation of chlorpyrifos to chlorpyrifos oxon and subsequently, the less neurotoxic end products. Chlorpyrifos was shown to concentration-dependently inhibit neurite length, neurite number, and branching in pure neuronal cultures more potently than in co-cultures with astrocytes, highlighting the protective role of astrocytes [207]. Addition of astrocytes to human dopaminergic neurons had been shown previously to increase metabolism, and thereby alter the sensitivity to chemical insults [208]. Inclusion of astrocytes in human neuronal cultures also enhances the development of neuronal networks and their spontaneous activity [209], as well as the synchrony of network activity [210], thus increasing the in vivo relevance of these models.
As a model compound for development of PD, the mitochondrial Complex I inhibitor rotenone is among the pesticides most studied in human neurons in vitro. Rotenone was shown to inhibit neurite growth in human dopaminergic neurons or human neuronal precursor cells differentiated towards dorsal root ganglia neurons [211]. In hiPSC-derived postmitotic mesencephalic dopamine neurons, rotenone also decreased neurite length. Additionally, rotenone decreased GSH levels and increased lipid peroxidation [212]. In mixed hiPSC-derived neuronal/glial cultures, rotenone exposure induces Nrf2 activation, resulting in astrocyte activation, decreased neurite length, and eventually cell death of dopaminergic neurons [213]. Recently, neurons differentiated from induced pluripotent stem cells derived from healthy and familial AD were used to investigate the effects of pyrazole insecticides, including fipronil, on generation of amyloid-β peptides, which play a key role in the development of AD. Interestingly, compared to wild-type neurons, neurons derived from the patient produced more amyloid-β42 peptide, which is associated with the onset of the disease [214].
Combined, these studies emphasize the potential of human (iPSC-derived) neuronal cultures for studying acute and developmental pesticide-induced neurotoxicity as well as pesticide-induced degeneration and disease development. While further characterization and toxicological validation are required for large-scale implementation of the use of human iPSC-based models for future neurotoxicity testing, the possibility to use patient-derived material holds great promise and may allow for further translation to behavioral and neuropathological findings in human clinical and epidemiological studies.
Conclusions
Pesticides represent one of the oldest and most used environmental contaminants. Although pesticides serve a useful and necessary purpose, there is significant potential for human exposure and potential toxicity. Higher level exposures that result from occupational exposures and proximity to agricultural spraying are associated with several neurotoxicities in humans. However, much remains to be learned regarding the potential effects of longerterm lower-level exposures, particularly in sub-populations that may be uniquely sensitive. Further, there are several pesticides that have been introduced relatively recently compared to the ones covered here (i.e. neonicitinoids, pyrazoles, biopesticides, etc.) for which there are emerging data regarding potential neurotoxicity. With the rapidly increasing world population, the need to generate higher crop yields to accommodate population growth, and the emergence and re-emergence of new and old vector-borne diseases, it is clear that pesticides will continue to be common in our environment and continued study is needed to understand the potential risks of exposure, particularly as it relates to neurotoxicity. Unfortunately, there are few human neuropathological data linked with pesticide exposures, with the exception of the Honolulu-Aging Asian Study [36]. Future collaborative work will be needed to monitor ongoing and new human cohort studies such that an autopsy component might be added. In the meantime, imaging modalities show great promise for exploring functional and structural changes following pesticide exposure in humans [215].
Abbreviations
- 2,4-D:
-
2,4-Dichlorophenoxyacetic acid
- AChE:
-
Acetylcholinesterase
- AD:
-
Alzheimer’s disease
- AOP:
-
Adverse outcome pathway
- APOE:
-
Apolipoprotein E
- BBB:
-
Blood–brain barrier
- BHC:
-
Beta-hexachlorocyclohexane
- DDE:
-
Dichlorodiphenyldichloroethylene
- DDT:
-
Dichlorodiphenyltrichloroethane
- DUMBBELS:
-
Diarrhea, urination miosis/muscle weakness, broncorrhea, bradycardia, emesis, lacrimation, salivation/sweating
- EPA:
-
US Environmental Protection Agency
- FDA:
-
US Food and Drug Administration
- GSH:
-
Glutathione
- IL1β:
-
Interleukin-1β
- IL6:
-
Interleukin 6
- iNOS:
-
Inducible nitric oxide synthase
- iPSC:
-
Induced pluripotent stem cell
- MEA:
-
Microelectrode array
- MRI:
-
Magnetic resonance imaging
- MN-EBCD:
-
Manganese ethylene-bis-dithiocarbamate
- MN/ZN-EBCD:
-
Manganese/Zinc ethylene-bis-dithiocarbamate
- MPP+ :
-
1-Methyl-4-phylpyridinium
- MPTP:
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- NOX2:
-
NADPH oxidase 2
- NSC:
-
Neural stem cell
- OP:
-
Organophosphate
- OPIDN:
-
Organophosphate-induced delayed neuropathy
- PD:
-
Parkinson’s disease
- PKC:
-
Protein kinase C
- SCG2:
-
Secretogranin II
- SOD:
-
Superoxide dismutase
- SNPc:
-
Substantia nigra pars compacta
- SLUD:
-
Salivation, lacrimation, urination, diarrhea
- TOCP:
-
Tri-ortho-cresyl phosphate
- TNFα:
-
Tumor necrosis factor alpha
- UPS:
-
Ubiquitin–proteasome system
- WHO:
-
World health organization
References
Costa LG (2013) Toxic Effects of Pesticides. In: Klaassen CD (ed) Casarett & Doull’s toxicology: the basic science of poisons. McGraw-Hill Education, New York
Atwood D, Paisley-Jones C (2017) Pesticides Industry Sales and Usage: 2008–2012 Market Estimates. Office of Pesticide Programs Office of Chemical Safety and Pollution Prevention. https://www.epa.gov/pesticides/pesticides-industry-sales-and-usage-2008-2012-market-estimates. Accessed 12 Mar 2019
Bonner MR, Alavanja MCR (2017) Pesticides, human health and food security. Food and Energy Secur 6:89–93
Bradman AS, Schwartz JM, Fenster L, Barr DB, Holland NT, Eskenazi B (2007) Factors predicting organochlorine pesticide levels in pregnant Latina women living in a United States agricultural area. J Expo Sci Environ Epidemiol 17:388–399. https://doi.org/10.1038/sj.jes.7500525
(ATSDR) AfTSaDR (2002) Toxicological Profile for DDT, DDE, DDD. US Department of Health and Human Services, Public Health Service. https://www.atsdr.cdc.gov/ToxProfiles/tp.asp?id=81&tid=20. Accessed 12 Mar 2019
(CDC) CfDCaP (2009) Fourth national report on human exposure to environmental chemicals. https://www.cdc.gov/exposurereport/index.html. Accessed 12 Mar 2019
(FDA) FaDA (2008) Pesticide Monitoring Program 2008. https://wayback.archive-it.org/7993/20170722164641/, https://www.fda.gov/Food/FoodborneIllnessContaminants/Pesticides/ucm229204.htm. Accessed 12 Mar 2019
Gaines TB (1969) Acute toxicity of pesticides. Toxicol Appl Pharmacol 14:515–534
Cueto C Jr, Durham WF, Hayes WJ Jr (1956) The effect of known repeated oral doses of chlorophenothane (DDT) in man. J Am Med Assoc 162:890–897
Morgan DP, Roan CC (1971) Absorption, storage, and metabolic conversion of ingested DDT and DDT metabolites in man. Arch Environ Health 22:301–308
Eskenazi B, Chevrier J, Rosas LG, Anderson HA, Bornman MS, Bouwman H et al (2009) The Pine River statement: human health consequences of DDT use. Environ Health Perspect 117:1359–1367. https://doi.org/10.1289/ehp.11748
Rogan WJ, Chen A (2005) Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT). Lancet 366:763–773. https://doi.org/10.1016/S0140-6736(05)67182-6
Misra UK, Nag D, Murti CR (1984) A study of cognitive functions in DDT sprayers. Ind Health 22:199–206
de Joode BVW, Wesseling C, Kromhout H, Monge P, Garcia M, Mergler D (2001) Chronic nervous-system effects of long-term occupational exposure to DDT. Lancet 357:1014–1016. https://doi.org/10.1016/s0140-6736(00)04249-5
Fleming L, Mann JB, Bean J, Briggle T, Sanchez-Ramos JR (1994) Parkinson’s disease and brain levels of organochlorine pesticides. Ann Neurol 36:100–103
Kim KS, Lee YM, Lee HW, Jacobs DR Jr, Lee DH (2015) Associations between organochlorine pesticides and cognition in U.S. elders: national health and nutrition examination survey 1999–2002. Environ Int 75:87–92. https://doi.org/10.1016/j.envint.2014.11.003
Richardson JR, Roy A, Shalat SL, von Stein RT, Hossain MM, Buckley B et al (2014) Elevated serum pesticide levels and risk for Alzheimer disease. JAMA Neurol 71:284–290. https://doi.org/10.1001/jamaneurol.2013.6030
Gaffney SH, Curriero FC, Strickland PT, Glass GE, Helzlsouer KJ, Breysse PN (2005) Influence of geographic location in modeling blood pesticide levels in a community surrounding a US environmental protection agency superfund site. Environ Health Perspect 113:1712–1716
Kreiss K, Zack MM, Kimbrough RD, Needham LL, Smrek AL, Jones BT (1981) Cross-sectional study of a community with exceptional exposure to DDT. JAMA 245:1926–1930
Hatcher JM, Richardson JR, Guillot TS, McCormack AL, Di Monte DA, Jones DP et al (2007) Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol 204:619–630
Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V (2005) Dieldrin-induced neurotoxicity: relevance to Parkinson’s disease pathogenesis. Neurotoxicology 26:701–719. https://doi.org/10.1016/j.neuro.2004.07.010
Richardson JR, Shalat SL, Buckley B, Winnik B, O’Suilleabhain P, Diaz-Arrastia R et al (2009) Elevated serum pesticide levels and risk of Parkinson disease. Arch Neurol 66:870–875. https://doi.org/10.1001/archneurol.2009.89
Jorgenson JL (2001) Aldrin and dieldrin: a review of research on their production, environmental deposition and fate, bioaccumulation, toxicology, and epidemiology in the United States. Environ Health Perspect 109(Suppl 1):113–139
Weisskopf MG, Knekt P, O’Reilly EJ, Lyytinen J, Reunanen A, Laden F et al (2010) Persistent organochlorine pesticides in serum and risk of Parkinson disease. Neurology 74:1055–1061. https://doi.org/10.1212/WNL.0b013e3181d76a93
Nair A, Dureja P, Pillai MK (1992) Aldrin and dieldrin residues in human fat, milk and blood serum collected from Delhi. Hum Exp Toxicol 11:43–45. https://doi.org/10.1177/096032719201100106
Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D (2000) Organochlorine insecticides in substantia nigra in Parkinson’s disease. J Toxicol Environ Health A 59:229–234
Bloomquist JR, Roush RT, Ffrench-Constant RH (1992) Reduced neuronal sensitivity to dieldrin and picrotoxinin in a cyclodiene-resistant strain of Drosophila melanogaster (Meigen). Arch Insect Biochem Physiol 19:17–25. https://doi.org/10.1002/arch.940190103
Kitazawa M, Anantharam V, Kanthasamy AG (2001) Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic Biol Med 31:1473–1485
Kanthasamy AG, Kitazawa M, Yang Y, Anantharam V, Kanthasamy A (2008) Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): implications for neurodegeneration in Parkinson’s disease. Mol Brain 1:12. https://doi.org/10.1186/1756-6606-1-12
Kitazawa M, Anantharam V, Kanthasamy AG (2003) Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience 119:945–964
Omurtag GZ, Tozan A, Sehirli AO, Sener G (2008) Melatonin protects against endosulfan-induced oxidative tissue damage in rats. J Pineal Res 44:432–438. https://doi.org/10.1111/j.1600-079X.2007.00546.x
Sun F, Anantharam V, Zhang D, Latchoumycandane C, Kanthasamy A, Kanthasamy AG (2006) Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models. Neurotoxicology 27:807–815. https://doi.org/10.1016/j.neuro.2006.06.006
Kitazawa M, Anantharam V, Kanthasamy A, Kanthasamy AG (2004) Dieldrin promotes proteolytic cleavage of poly(ADP-ribose) polymerase and apoptosis in dopaminergic cells: protective effect of mitochondrial anti-apoptotic protein Bcl-2. Neurotoxicology 25:589–598. https://doi.org/10.1016/j.neuro.2003.09.014
Richardson JR, Caudle WM, Wang M, Dean ED, Pennell KD, Miller GW (2006) Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson’s disease. FASEB J 20:1695–1697. https://doi.org/10.1096/fj.06-5864fje
Richardson JR, Caudle WM, Wang MZ, Dean ED, Pennell KD, Miller GW (2008) Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner. Neurotoxicology 29:855–863. https://doi.org/10.1016/j.neuro.2008.05.007
Ross GW, Abbott RD, Petrovitch H, Duda JE, Tanner CM, Zarow C et al (2019) Association of brain heptachlor epoxide and other organochlorine compounds with lewy pathology. Mov Disord 34:228–235. https://doi.org/10.1002/mds.27594
Song C, Kanthasamy A, Anantharam V, Sun F, Kanthasamy AG (2010) Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration. Mol Pharmacol 77:621–632. https://doi.org/10.1124/mol.109.062174
Lubick N (2010) Environment. Endosulfan’s exit: US EPA pesticide review leads to a ban. Science 328:1466. https://doi.org/10.1126/science.328.5985.1466
Seth PK, Saidi NF, Agrawal AK, Anand M (1986) Neurotoxicity of endosulfan in young and adult rats. Neurotoxicology 7:623–635
Silva MH, Gammon D (2009) An assessment of the developmental, reproductive, and neurotoxicity of endosulfan. Birth Defects Res B Dev Reprod Toxicol 86:1–28. https://doi.org/10.1002/bdrb.20183
Aleksandrowicz DR (1979) Endosulfan poisoning and chronic brain syndrome. Arch Toxicol 43:65–68
Kang KS, Park JE, Ryu DY, Lee YS (2001) Effects and neuro-toxic mechanisms of 2, 2′, 4, 4′, 5, 5′-hexachlorobiphenyl and endosulfan in neuronal stem cells. J Vet Med Sci 63:1183–1190
Chan MP, Morisawa S, Nakayama A, Kawamoto Y, Yoneda M (2006) Development of an in vitro blood–brain barrier model to study the effects of endosulfan on the permeability of tight junctions and a comparative study of the cytotoxic effects of endosulfan on rat and human glial and neuronal cell cultures. Environ Toxicol 21:223–235
Wilson WW, Shapiro LP, Bradner JM, Caudle WM (2014) Developmental exposure to the organochlorine insecticide endosulfan damages the nigrostriatal dopamine system in male offspring. Neurotoxicology 44:279–287. https://doi.org/10.1016/j.neuro.2014.07.008
Jia Z, Misra HP (2007) Developmental exposure to pesticides zineb and/or endosulfan renders the nigrostriatal dopamine system more susceptible to these environmental chemicals later in life. Neurotoxicology 28:727–735. https://doi.org/10.1016/j.neuro.2007.04.003
Lafuente A, Pereiro N (2013) Neurotoxic effects induced by endosulfan exposure during pregnancy and lactation in female and male rat striatum. Toxicology 311:35–40. https://doi.org/10.1016/j.tox.2013.05.001
Lee I, Eriksson P, Fredriksson A, Buratovic S, Viberg H (2015) Developmental neurotoxic effects of two pesticides: behavior and neuroprotein studies on endosulfan and cypermethrin. Toxicology 335:1–10. https://doi.org/10.1016/j.tox.2015.06.010
Lakroun Z, Kebieche M, Lahouel A, Zama D, Desor F, Soulimani R (2015) Oxidative stress and brain mitochondria swelling induced by endosulfan and protective role of quercetin in rat. Environ Sci Pollut Res Int 22:7776–7781. https://doi.org/10.1007/s11356-014-3885-5
Tucker JB (2006) IG Farber. In: Tucker JB (ed) War of nerves: chemical warfare from world War I to Al-Qaeda. Pantheon Books, New York, pp 24–41
Casida JE (2017) Organophosphorus xenobiotic toxicology. Annu Rev Pharmacol Toxicol 57:309–327. https://doi.org/10.1146/annurev-pharmtox-010716-104926
Hodgson E, Rose RL (2007) Human metabolic interactions of environmental chemicals. J Biochem Mol Toxicol 21:182–186
Jett DA, Richardson JR (2009) Neurotoxic pesticides. In: Dobbs MR (ed) Clinical neurotoxicology: syndromes, substances, environments. Saunders Elsevier, Philadelphia, pp 491–499
Pope C, Karanth S, Liu J (2005) Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. Environ Toxicol Pharmacol 19:433–446. https://doi.org/10.1016/j.etap.2004.12.048
Karalliedde L, Baker D, Marrs TC (2006) Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy. Toxicol Rev 25:1–14
Lotti M, Moretto A (2005) Organophosphate-induced delayed polyneuropathy. Toxicol Rev 24:37–49
Morgan JP, Penovich P (1978) Jamaica ginger paralysis. Forty-seven-year follow-up. Arch Neurol 35:530–532
Richardson RJ, Hein ND, Wijeyesakere SJ, Fink JK, Makhaeva GF (2013) Neuropathy target esterase (NTE): overview and future. Chem Biol Interact 203:238–244. https://doi.org/10.1016/j.cbi.2012.10.024
Munoz-Quezada MT, Lucero BA, Iglesias VP, Munoz MP, Cornejo CA, Achu E et al (2016) Chronic exposure to organophosphate (OP) pesticides and neuropsychological functioning in farm workers: a review. Int J Occup Environ Health 22:68–79. https://doi.org/10.1080/10773525.2015.1123848
Ross SM, McManus IC, Harrison V, Mason O (2013) Neurobehavioral problems following low-level exposure to organophosphate pesticides: a systematic and meta-analytic review. Crit Rev Toxicol 43:21–44. https://doi.org/10.3109/10408444.2012.738645
Sanchez-Santed F, Colomina MT, Herrero Hernandez E (2016) Organophosphate pesticide exposure and neurodegeneration. Cortex 74:417–426. https://doi.org/10.1016/j.cortex.2015.10.003
Hayden KM, Norton MC, Darcey D, Ostbye T, Zandi PP, Breitner JC, Cache County Study I et al (2010) Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology 74:1524–1530. https://doi.org/10.1212/wnl.0b013e3181dd4423
Parron T, Requena M, Hernandez AF, Alarcon R (2011) Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol Appl Pharmacol 256:379–385. https://doi.org/10.1016/j.taap.2011.05.006
Kamel F, Umbach DM, Bedlack RS, Richards M, Watson M, Alavanja MC et al (2012) Pesticide exposure and amyotrophic lateral sclerosis. Neurotoxicology 33:457–462. https://doi.org/10.1016/j.neuro.2012.04.001
Faustman EM, Silbernagel SM, Fenske RA, Burbacher TM, Ponce RA (2000) Mechanisms underlying Children’s susceptibility to environmental toxicants. Environ Health Perspect 108(Suppl 1):13–21
Burke RD, Todd SW, Lumsden E, Mullins RJ, Mamczarz J, Fawcett WP et al (2017) Developmental neurotoxicity of the organophosphorus insecticide chlorpyrifos: from clinical findings to preclinical models and potential mechanisms. J Neurochem 142(Suppl 2):162–177. https://doi.org/10.1111/jnc.14077
Hertz-Picciotto I, Sass JB, Engel S, Bennett DH, Bradman A, Eskenazi B et al (2018) Organophosphate exposures during pregnancy and child neurodevelopment: recommendations for essential policy reforms. PLoS Med 15:e1002671. https://doi.org/10.1371/journal.pmed.1002671
Terry AV Jr (2012) Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms. Pharmacol Ther 134:355–365. https://doi.org/10.1016/j.pharmthera.2012.03.001
Singh N, Lawana V, Luo J, Phong P, Abdalla A, Palanisamy B et al (2018) Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: implications for mitochondria mediated oxidative stress signaling events. Neurobiol Dis 117:82–113. https://doi.org/10.1016/j.nbd.2018.05.019
Shafer TJ, Meyer DA, Crofton KM (2005) Developmental neurotoxicity of pyrethroid insecticides: critical review and future research needs. Environ Health Perspect 113:123–136
van den Berg H, Zaim M, Yadav RS, Soares A, Ameneshewa B, Mnzava A et al (2012) Global trends in the use of insecticides to control vector-borne diseases. Environ Health Perspect 120:577–582. https://doi.org/10.1289/ehp.1104340
WHO (2011) Global insecticide use for vector-borne disease control: a 10-year assessment, 2000–2009. 5th edn. https://www.who.int/whopes/resources/9789241598781/en/. Accessed 12 Mar 2019
Tang W, Wang D, Wang J, Wu Z, Li L, Huang M et al (2018) Pyrethroid pesticide residues in the global environment: an overview. Chemosphere 191:990–1007. https://doi.org/10.1016/j.chemosphere.2017.10.115
Narahashi T (1996) Neuronal ion channels as the target sites of insecticides. Pharmacol Toxicol 79:1–14
Soderlund DM (2012) Molecular mechanisms of pyrethroid insecticide neurotoxicity: recent advances. Arch Toxicol 86:165–181. https://doi.org/10.1007/s00204-011-0726-x
Casida JE, Gammon DW, Glickman AH, Lawrence LJ (1983) Mechanisms of selective action of pyrethroid insecticides. Annu Rev Pharmacol Toxicol 23:413–438. https://doi.org/10.1146/annurev.pa.23.040183.002213
Crow JA, Borazjani A, Potter PM, Ross MK (2007) Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. Toxicol Appl Pharmacol 221:1–12. https://doi.org/10.1016/j.taap.2007.03.002
Godin SJ, DeVito MJ, Hughes MF, Ross DG, Scollon EJ, Starr JM et al (2010) Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model. Toxicol Sci 115:330–343. https://doi.org/10.1093/toxsci/kfq051
Kamel F, Engel LS, Gladen BC, Hoppin JA, Alavanja MC, Sandler DP (2005) Neurologic symptoms in licensed private pesticide applicators in the agricultural health study. Environ Health Perspect 113:877–882
Muller-Mohnssen H (1999) Chronic sequelae and irreversible injuries following acute pyrethroid intoxication. Toxicol Lett 107:161–176
Richardson JR, Taylor MM, Shalat SL, Guillot TS 3rd, Caudle WM, Hossain MM et al (2015) Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder. FASEB J 29:1960–1972. https://doi.org/10.1096/fj.14-260901
Wagner-Schuman M, Richardson JR, Auinger P, Braun JM, Lanphear BP et al (2015) Association of pyrethroid pesticide exposure with attention-deficit/hyperactivity disorder in a nationally representative sample of US children. Environ Health 14:44. https://doi.org/10.1186/s12940-015-0030-y
Sheets LP (2000) A consideration of age-dependent differences in susceptibility to organophosphorus and pyrethroid insecticides. Neurotoxicology 21:57–63
Anand SS, Kim KB, Padilla S, Muralidhara S, Kim HJ, Fisher JW et al (2006) Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity. Drug Metab Dispos 34:389–397. https://doi.org/10.1124/dmd.105.007807
Fortin MC, Aleksunes LM, Richardson JR (2013) Alteration of the expression of pesticide-metabolizing enzymes in pregnant mice: potential role in the increased vulnerability of the developing brain. Drug Metab Dispos 41:326–331. https://doi.org/10.1124/dmd.112.049395
Kim KB, Anand SS, Kim HJ, White CA, Fisher JW, Tornero-Velez R et al (2010) Age, dose, and time-dependency of plasma and tissue distribution of deltamethrin in immature rats. Toxicol Sci 115:354–368. https://doi.org/10.1093/toxsci/kfq074
Tornero-Velez R, Mirfazaelian A, Kim KB, Anand SS, Kim HJ, Haines WT et al (2010) Evaluation of deltamethrin kinetics and dosimetry in the maturing rat using a PBPK model. Toxicol Appl Pharmacol 244:208–217. https://doi.org/10.1016/j.taap.2009.12.034
Amaraneni M, Pang J, Mortuza TB, Muralidhara S, Cummings BS, White CA et al (2017) Brain uptake of deltamethrin in rats as a function of plasma protein binding and blood–brain barrier maturation. Neurotoxicology 62:24–29. https://doi.org/10.1016/j.neuro.2017.04.009
Wolansky MJ, Harrill JA (2008) Neurobehavioral toxicology of pyrethroid insecticides in adult animals: a critical review. Neurotoxicol Teratol 30:55–78. https://doi.org/10.1016/j.ntt.2007.10.005
Hossain MM, DiCicco-Bloom E, Richardson JR (2015) Hippocampal ER stress and learning deficits following repeated pyrethroid exposure. Toxicol Sci 143:220–228. https://doi.org/10.1093/toxsci/kfu226
Hossain MM, Richardson JR (2011) Mechanism of pyrethroid pesticide-induced apoptosis: role of calpain and the ER stress pathway. Toxicol Sci 122:512–525. https://doi.org/10.1093/toxsci/kfr111
Hossain MM, Sivaram G, Richardson JR (2019) Regional susceptibility to er stress and protection by salubrinal following a single exposure to deltamethrin. Toxicol Sci 167:249–257. https://doi.org/10.1093/toxsci/kfy238
Agrawal S, Singh A, Tripathi P, Mishra M, Singh PK, Singh MP (2015) Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study. Mol Neurobiol 51:448–465. https://doi.org/10.1007/s12035-014-8696-7
Gargouri B, Bhatia HS, Bouchard M, Fiebich BL, Fetoui H (2018) Inflammatory and oxidative mechanisms potentiate bifenthrin-induced neurological alterations and anxiety-like behavior in adult rats. Toxicol Lett 294:73–86. https://doi.org/10.1016/j.toxlet.2018.05.020
Gargouri B, Yousif NM, Bouchard M, Fetoui H, Fiebich BL (2018) Inflammatory and cytotoxic effects of bifenthrin in primary microglia and organotypic hippocampal slice cultures. J Neuroinflammation 15:159. https://doi.org/10.1186/s12974-018-1198-1
Hossain MM, Liu J, Richardson JR (2017) pyrethroid insecticides directly activate microglia through interaction with voltage-gated sodium channels. Toxicol Sci 155:112–123. https://doi.org/10.1093/toxsci/kfw187
Singh A, Tripathi P, Prakash O, Singh MP (2016) Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration. Mol Neurobiol 53:6849–6858. https://doi.org/10.1007/s12035-015-9577-4
Hossain MM, Weig B, Reuhl K, Gearing M, Wu LJ, Richardson JR (2018) The anti-parkinsonian drug zonisamide reduces neuroinflammation: role of microglial Nav 1.6. Exp Neurol 308:111–119. https://doi.org/10.1016/j.expneurol.2018.07.005
White RF, Steele L, O’Callaghan JP, Sullivan K, Binns JH, Golomb BA et al (2016) Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: effects of toxicant exposures during deployment. Cortex 74:449–475. https://doi.org/10.1016/j.cortex.2015.08.022
Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T et al (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson’s disease. Biochem Biophys Res Commun 163:1450–1455
Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet 1:1269
Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54:823–827
Keeney PM, Xie J, Capaldi RA, Bennett JP Jr (2006) Parkinson’s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26:5256–5264. https://doi.org/10.1523/JNEUROSCI.0984-06.2006
Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979–980
Richardson JR, Caudle WM, Guillot TS, Watson JL, Nakamaru-Ogiso E, Seo BB et al (2007) Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Sci 95:196–204. https://doi.org/10.1093/toxsci/kfl133
Greenamyre JT, Sherer TB, Betarbet R, Panov AV (2001) Complex I and Parkinson’s disease. IUBMB Life 52:135–141. https://doi.org/10.1080/15216540152845939
Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci 3:1301–1306. https://doi.org/10.1038/81834
Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M et al (2011) Rotenone, paraquat, and Parkinson’s disease. Environ Health Perspect 119:866–872. https://doi.org/10.1289/ehp.1002839
Terron A, Bal-Price A, Paini A, Monnet-Tschudi F, Bennekou SH, Leist M et al (2018) An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition. Arch Toxicol 92:41–82. https://doi.org/10.1007/s00204-017-2133-4
Dhillon AS, Tarbutton GL, Levin JL, Plotkin GM, Lowry LK, Nalbone JT et al (2008) Pesticide/environmental exposures and Parkinson’s disease in east texas. J Agromedicine 13:37–48. https://doi.org/10.1080/10599240801986215
Pouchieu C, Piel C, Carles C, Gruber A, Helmer C, Tual S et al (2018) Pesticide use in agriculture and Parkinson’s disease in the AGRICAN cohort study. Int J Epidemiol 47:299–310. https://doi.org/10.1093/ije/dyx225
Johnson ME, Bobrovskaya L (2015) An update on the rotenone models of Parkinson’s disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology 46:101–116. https://doi.org/10.1016/j.neuro.2014.12.002
Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH et al (2003) Mechanism of toxicity in rotenone models of Parkinson’s disease. J Neurosci 23:10756–10764
Zhang ZN, Zhang JS, Xiang J, Yu ZH, Zhang W, Cai M et al (2017) Subcutaneous rotenone rat model of Parkinson’s disease: dose exploration study. Brain Res 1655:104–113. https://doi.org/10.1016/j.brainres.2016.11.020
Hoglinger GU, Feger J, Prigent A, Michel PP, Parain K, Champy P et al (2003) Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 84:491–502
Sanders LH, Greenamyre JT (2013) Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic Biol Med 62:111–120. https://doi.org/10.1016/j.freeradbiomed.2013.01.003
Liu HQ, Zhu XZ, Weng EQ (2005) Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells. Acta Pharmacol Sin 26:17–26. https://doi.org/10.1111/j.1745-7254.2005.00003.x
Silva BA, Einarsdóttir O, Fink AL, Uversky VN (2013) Biophysical characterization of α-synuclein and rotenone interaction. Biomolecules 3:703–732. https://doi.org/10.3390/biom3030703
Yuan YH, Yan WF, Sun JD, Huang JY, Mu Z, Chen NH (2015) The molecular mechanism of rotenone-induced α-synuclein aggregation: emphasizing the role of the calcium/GSK3β pathway. Toxicol Lett 233:163–171. https://doi.org/10.1016/j.toxlet.2014.11.029
Chu CT, Bayır H, Kagan VE (2014) LC3 binds externalized cardiolipin on injured mitochondria to signal mitophagy in neurons: implications for Parkinson disease. Autophagy 10:376–378. https://doi.org/10.4161/auto.27191
Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA et al (2013) Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol 15:1197–1205. https://doi.org/10.1038/ncb2837
Gao F, Chen D, Hu Q, Wang G (2013) Rotenone directly induces BV2 cell activation via the p38 MAPK pathway. PLoS One 8:e72046. https://doi.org/10.1371/journal.pone.0072046
Zhou H, Zhang F, Chen SH, Zhang D, Wilson B, Hong JS et al (2012) Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox. Free Radic Biol Med 52:303–313. https://doi.org/10.1016/j.freeradbiomed.2011.10.488
Sarkar S, Malovic E, Harishchandra DS, Ghaisas S, Panicker N, Charli A et al (2017) Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease. NPJ Parkinsons Dis 3:30. https://doi.org/10.1038/s41531-017-0032-2
Schuler F, Yano T, Di Bernardo S, Yagi T, Yankovskaya V et al (1999) NADH-quinone oxidoreductase: PSST subunit couples electron transfer from iron-sulfur cluster N2 to quinone. Proc Natl Acad Sci U S A 96:4149–4153
Calvert GM, Rodriguez L, Prado JB, (CDC) CfDCaP (2015) Worker illness related to newly marketed pesticides–Douglas County, Washington, 2014. MMWR Morb Mortal Wkly Rep 64:42–44
Gendelman HE, Anantharam V, Bronich T, Ghaisas S, Jin H, Kanthasamy AG et al (2015) Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine 11:751–767. https://doi.org/10.1016/j.nano.2014.12.014
Charli A, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2015) Alterations in mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic neuronal cell culture model. Neurotoxicology. https://doi.org/10.1016/j.neuro.2015.06.007
Sherer TB, Richardson JR, Testa CM, Seo BB, Panov AV, Yagi T et al (2007) Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s disease. J Neurochem 100:1469–1479. https://doi.org/10.1111/j.1471-4159.2006.04333.x
Gollamudi S, Johri A, Calingasan NY, Yang L, Elemento O, Beal MF (2012) Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson’s disease. PLoS One 7:e36191. https://doi.org/10.1371/journal.pone.0036191
Hoglinger GU, Carrard G, Michel PP, Medja F, Lombes A, Ruberg M et al (2003) Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson’s disease. J Neurochem 86:1297–1307
Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M et al (2003) An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res 74:589–597. https://doi.org/10.1002/jnr.10777
Branco DM, Arduino DM, Esteves AR, Silva DF, Cardoso SM, Oliveira CR (2010) Cross-talk between mitochondria and proteasome in Parkinson’s disease pathogenesis. Front Aging Neurosci 2:17. https://doi.org/10.3389/fnagi.2010.00017
Benbrook CM (2016) Trends in glyphosate herbicide use in the United States and globally. Environ Sci Eur 28:3. https://doi.org/10.1186/s12302-016-0070-0
PubMed.gov (2018) Analytics by year: toxicity of glyphosate (filtered for “Humans”) https://www.ncbi.nlm.nih.gov/pubmed/?term=toxicity+of+glyphosate. Accessed 10 July 2018
Duke SO (1990) Overview of herbicide mechanisms of action. Environ Health Perspect 87:263–271
Tomlin CDS (2006) The pesticide manual: a world compendium, 14 edn. British Crop Protection Council, Hampshire, UK, pp 545–548
Defarge N, Spiroux de Vendomois J, Seralini GE (2018) Toxicity of formulants and heavy metals in glyphosate-based herbicides and other pesticides. Toxicol Rep 5:156–163. https://doi.org/10.1016/j.toxrep.2017.12.025
Peixoto F (2005) Comparative effects of the Roundup and glyphosate on mitochondrial oxidative phosphorylation. Chemosphere 61:1115
Kwiatkowska M, Nowacka-Krukowska H, Bukowska B (2014) The effect of glyphosate, its metabolites and impurities on erythrocyte acetylcholinesterase activity. Environ Toxicol Pharmacol 37:1101–1108. https://doi.org/10.1016/j.etap.2014.04.008
El-Demerdash FM, Yousef MI, Elagamy EI (2001) Influence of paraquat, glyphosate, and cadmium on the activity of some serum enzymes and protein electrophoretic behavior (in vitro). J Environ Sci Health B 36:29–42
Negga R, Rudd DA, Davis NS, Justice AN, Hatfield HE, Valente AL, Fields AS, Fitsanakis VA (2011) Exposure to Mn/Zn Ethylene-bis-dithiocarbamate and glyphosate pesticides leads to neurodegeneration in Caenorhabditis elegans. Neurotoxicology 32:331–341. https://doi.org/10.1016/j.neuro.2011.02.002
Negga R, Stuart JA, Machen ML, Salva J, Lizek AJ, Richardson SJ et al (2012) Exposure to glyphosate- and/or Mn/Zn-ethylene-bis-dithiocarbamate-containing pesticides leads to degeneration of gamma-aminobutyric acid and dopamine neurons in Caenorhabditis elegans. Neurotox Res 21:281–290. https://doi.org/10.1007/s12640-011-9274-7
Bailey DC, Todt CE, Burchfield SL, Pressley AS, Denney RD, Snapp IB et al (2017) Chronic exposure to a glyphosate-containing pesticide leads to mitochondrial dysfunction and increased reactive oxygen species production in Caenorhabditis elegans. Environ Toxicol Pharmacol 57:46–52. https://doi.org/10.1016/j.etap.2017.11.005
Bridi D, Altenhofen S, Gonzalez JB, Reolon GK, Bonan CD (2017) Glyphosate and Roundup((R)) alter morphology and behavior in zebrafish. Toxicology 392:32–39. https://doi.org/10.1016/j.tox.2017.10.007
Roy NM, Carneiro B, Ochs J (2016) Glyphosate induces neurotoxicity in zebrafish. Environ Toxicol Pharmacol 42:45–54. https://doi.org/10.1016/j.etap.2016.01.003
Cattani D, Cesconetto PA, Tavares MK, Parisotto EB, De Oliveira PA, Rieg CEH et al (2017) Developmental exposure to glyphosate-based herbicide and depressive-like behavior in adult offspring: implication of glutamate excitotoxicity and oxidative stress. Toxicology 387:67–80. https://doi.org/10.1016/j.tox.2017.06.001
Cattani D, Cavalli VLDLO, Heinz Rieg CE, Domingues JT, Dal-Cim T, Tasca CI et al (2014) Mechanisms underlying the neurotoxicity induced by glyphosate-based herbicide in immature rat hippocampus: involvement of glutamate excitotoxicity. Toxicology 320:34–45. https://doi.org/10.1016/j.tox.2014.03.001
Aitbali Y, Ba-M’hamed S, Elhidar N, Nafis A, Soraa N, Bennis M (2018) Glyphosate based- herbicide exposure affects gut microbiota, anxiety and depression-like behaviors in mice. Neurotoxicol Teratol 67:44–49. https://doi.org/10.1016/j.ntt.2018.04.002
Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002) The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277:1641–1644. https://doi.org/10.1074/jbc.C100560200
McCormack AL, Atienza JG, Johnston LC, Andersen JK, Vu S, Di Monte DA (2005) Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J Neurochem 93:1030–1037. https://doi.org/10.1111/j.1471-4159.2005.03088.x
McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA et al (2002) Environmental risk factors and Parkinson’s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10:119–127
Purisai MG, McCormack AL, Cumine S, Li J, Isla MZ, Di Monte DA (2007) Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol Dis 25:392–400. https://doi.org/10.1016/j.nbd.2006.10.008
Ali SF, Binienda ZK, Imam SZ (2011) Molecular aspects of dopaminergic neurodegeneration: gene-environment interaction in parkin dysfunction. Int J Environ Res Public Health 8:4702–4713. https://doi.org/10.3390/ijerph8124702
Song C, Kanthasamy A, Jin H, Anantharam V, Kanthasamy AG (2011) Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration. Neurotoxicology 32:586–595. https://doi.org/10.1016/j.neuro.2011.05.018
Chinta SJ, Woods G, Demaria M, Rane A, Zou Y, McQuade A et al (2018) Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson’s disease. Cell Rep 22:930–940. https://doi.org/10.1016/j.celrep.2017.12.092
Zhan X, Li F, Chu Q, Pang H (2018) Effects of PQ’s cytotoxicity on secretory vesicles in astroglia: expression alternation of secretogranin II and its potential interaction with intracellular factors. Biochem Biophys Res Commun 497:675–682. https://doi.org/10.1016/j.bbrc.2018.02.130
Morton V, Staub T (2008) A short history of fungicides http://www.apsnet.org/publications/apsnetfeatures/Pages/Fungicides.aspx. Accessed 15 July 2018
Bakir F, Damluji SF, Amin-Zaki L, Murtadha M, Khalidi A, Al-Rawi NY, Tikriti S et al (1973) Methylmercury poisoning in Iraq. Science 181:230–241
Cox C, Marsh D, Myers G, Clarkson T (1995) Analysis of data on delayed development from the 1971–72 outbreak of methylmercury poisoning in Iraq: assessment of influential points. Neurotoxicology 16:727–730
Greenwood MR (1985) Methylmercury poisoning in Iraq. An epidemiological study of the 1971-1972 outbreak. J Appl Toxicol 5:148–159
Roberts JR, Reigart JR (2013) Recognition and management of pesticide poisonings, 6th edn. United States Environmental Protection Agency, Washington, DC
Mora AM, Cordoba L, Cano JC, Hernandez-Bonilla D, Pardo L, Schnaas L et al (2018) Prenatal mancozeb exposure, excess manganese, and neurodevelopment at 1 year of age in the infants’ environmental health (ISA) study. Environ Health Perspect 126:057007. https://doi.org/10.1289/EHP1955
Hoffman L, Trombetta L, Hardej D (2016) Ethylene bisdithiocarbamate pesticides maneb and mancozeb cause metal overload in human colon cells. Environ Toxicol Pharmacol 41:78–88. https://doi.org/10.1016/j.etap.2015.11.002
Costa-Silva DG, Lopes AR, Martins IK, Leandro LP, Nunes MEM, de Carvalho NR et al (2018) Mancozeb exposure results in manganese accumulation and Nrf2-related antioxidant responses in the brain of common carp Cyprinus carpio. Environ Sci Pollut Res Int 25:15529–15540. https://doi.org/10.1007/s11356-018-1724-9
Barlow BK, Lee DW, Cory-Slechta DA, Opanashuk LA (2005) Modulation of antioxidant defense systems by the environmental pesticide maneb in dopaminergic cells. Neurotoxicology 26:63
Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B (2009) Parkinson’s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol 169:919–926
Meco G, Bonifati V, Vanacore N, Fabrizio E (1994) Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). Scand J Work Environ Health 20:301–305
Brody AH, Chou E, Gray JM, Pokyrwka NJ, Raley-Susman KM (2013) Mancozeb-induced behavioral deficits precede structural neural degeneration. Neurotoxicology 34:74–81. https://doi.org/10.1016/j.neuro.2012.10.007
Montgomery K, Corona C, Frye R, Barnett R, Bailey A, Fitsanakis VA (2018) Transport of a manganese/zinc ethylene-bis-dithiocarbamate fungicide may involve pre-synaptic dopaminergic transporters. Neurotoxicol Teratol 68:66–71. https://doi.org/10.1016/j.ntt.2018.05.004
Domico LM, Cooper KR, Bernard LP, Zeevalk GD (2007) Reactive oxygen species generation by the ethylene-bis-dithiocarbamate (EBDC) fungicide mancozeb and its contribution to neuronal toxicity in mesencephalic cells. Neurotoxicology 28:1079–1091
Iorio R, Castellucci A, Rossi G, Cinque B, Cifone MG, Macchiarelli G et al (2015) Mancozeb affects mitochondrial activity, redox status and ATP production in mouse granulosa cells. Toxicol In Vitro 30:438–445. https://doi.org/10.1016/j.tiv.2015.09.018
Meme S, Calas AG, Montecot C, Richard O, Gautier H, Gefflaut T et al (2009) MRI characterization of structural mouse brain changes in response to chronic exposure to the glufosinate ammonium herbicide. Toxicol Sci 111:321–330. https://doi.org/10.1093/toxsci/kfp174
Shrot S, Tauber M, Shiyovich A, Milk N, Rosman Y, Eisenkraft A et al (2015) Early brain magnetic resonance imaging can predict short and long-term outcomes after organophosphate poisoning in a rat model. Neurotoxicology 48:206–216. https://doi.org/10.1016/j.neuro.2015.04.003
Hernandez CM, Beck WD, Naughton SX, Poddar I, Adam BL, Yanasak N et al (2015) Repeated exposure to chlorpyrifos leads to prolonged impairments of axonal transport in the living rodent brain. Neurotoxicology 47:17–26. https://doi.org/10.1016/j.neuro.2015.01.002
Johnstone AF, Gross GW, Weiss DG, Schroeder OH, Gramowski A, Shafer TJ (2010) Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century. Neurotoxicology 31:331–350. https://doi.org/10.1016/j.neuro.2010.04.001
Gross GW, Rhoades BK, Azzazy HM, Wu MC (1995) The use of neuronal networks on multielectrode arrays as biosensors. Biosens Bioelectron 10:553–567
Hondebrink L, Verboven AHA, Drega WS, Schmeink S, de Groot M, van Kleef R et al (2016) Neurotoxicity screening of (illicit) drugs using novel methods for analysis of microelectrode array (MEA) recordings. Neurotoxicology 55:1–9. https://doi.org/10.1016/j.neuro.2016.04.020
Meyer DA, Carter JM, Johnstone AF, Shafer TJ (2008) Pyrethroid modulation of spontaneous neuronal excitability and neurotransmission in hippocampal neurons in culture. Neurotoxicology 29:213–225. https://doi.org/10.1016/j.neuro.2007.11.005
Shafer TJ, Rijal SO, Gross GW (2008) Complete inhibition of spontaneous activity in neuronal networks in vitro by deltamethrin and permethrin. Neurotoxicology 29:203–212. https://doi.org/10.1016/j.neuro.2008.01.002
Mohana Krishnan B, Prakhya BM (2016) In vitro evaluation of pyrethroid-mediated changes on neuronal burst parameters using microelectrode arrays. Neurotoxicology 57:270–281. https://doi.org/10.1016/j.neuro.2016.10.007
Vassallo A, Chiappalone M, De Camargos Lopes R, Scelfo B, Novellino A, Defranchi E, Palosaari T et al (2017) A multi-laboratory evaluation of microelectrode array-based measurements of neural network activity for acute neurotoxicity testing. Neurotoxicology 60:280–292. https://doi.org/10.1016/j.neuro.2016.03.019
Dingemans MM, Schutte MG, Wiersma DM, de Groot A, van Kleef RG et al (2016) Chronic 14-day exposure to insecticides or methylmercury modulates neuronal activity in primary rat cortical cultures. Neurotoxicology 57:194–202. https://doi.org/10.1016/j.neuro.2016.10.002
Johnstone AFM, Strickland JD, Crofton KM, Gennings C, Shafer TJ (2017) Effects of an environmentally-relevant mixture of pyrethroid insecticides on spontaneous activity in primary cortical networks on microelectrode arrays. Neurotoxicology 60:234–239. https://doi.org/10.1016/j.neuro.2016.05.005
Mack CM, Lin BJ, Turner JD, Johnstone AF, Burgoon LD, Shafer TJ (2014) Burst and principal components analyses of MEA data for 16 chemicals describe at least three effects classes. Neurotoxicology 40:75–85. https://doi.org/10.1016/j.neuro.2013.11.008
Lantz SR, Mack CM, Wallace K, Key EF, Shafer TJ, Casida JE (2014) Glufosinate binds N-methyl-d-aspartate receptors and increases neuronal network activity in vitro. Neurotoxicology 45:38–47. https://doi.org/10.1016/j.neuro.2014.09.003
Croom EL, Shafer TJ, Evans MV, Mundy WR, Eklund CR, Johnstone AF et al (2015) Improving in vitro to in vivo extrapolation by incorporating toxicokinetic measurements: a case study of lindane-induced neurotoxicity. Toxicol Appl Pharmacol 283:9–19. https://doi.org/10.1016/j.taap.2014.11.006
Heusinkveld HJ, Thomas GO, Lamot I, van den Berg M, Kroese AB, Westerink RH (2010) Dual actions of lindane (gamma-hexachlorocyclohexane) on calcium homeostasis and exocytosis in rat PC12 cells. Toxicol Appl Pharmacol 248:12–19. https://doi.org/10.1016/j.taap.2010.06.013
Scelfo B, Politi M, Reniero F, Palosaari T, Whelan M, Zaldivar JM (2012) Application of multielectrode array (MEA) chips for the evaluation of mixtures neurotoxicity. Toxicology 299:172–183. https://doi.org/10.1016/j.tox.2012.05.020
Cao Z, Shafer TJ, Crofton KM, Gennings C, Murray TF (2011) Additivity of pyrethroid actions on sodium influx in cerebrocortical neurons in primary culture. Environ Health Perspect 119:1239–1246. https://doi.org/10.1289/ehp.1003394
Mwila K, Burton MH, Van Dyk JS, Pletschke BI (2013) The effect of mixtures of organophosphate and carbamate pesticides on acetylcholinesterase and application of chemometrics to identify pesticides in mixtures. Environ Monit Assess 185:2315–2327. https://doi.org/10.1007/s10661-012-2711-0
Richardson JR, Chambers HW, Chambers JE (2001) Analysis of the additivity of in vitro inhibition of cholinesterase by mixtures of chlorpyrifos-oxon and azinphos-methyl-oxon. Toxicol Appl Pharmacol 172:128–139. https://doi.org/10.1006/taap.2001.9140
Gomez-Gimenez B, Llansola M, Cabrera-Pastor A, Hernandez-Rabaza V, Agusti A, Felipo V (2018) Endosulfan and cypermethrin pesticide mixture induces synergistic or antagonistic effects on developmental exposed rats depending on the analyzed behavioral or neurochemical end points. ACS Chem Neurosci 9:369–380. https://doi.org/10.1021/acschemneuro.7b00364
Avila D, Helmcke K, Aschner M (2012) The Caenorhabditis elegans model as a reliable tool in neurotoxicology. Hum Exp Toxicol 31:236–243. https://doi.org/10.1177/0960327110392084
Ruszkiewicz JA, Pinkas A, Miah MR, Weitz RL, Lawes MJA, Akinyemi AJ et al (2018) C. elegans as a model in developmental neurotoxicology. Toxicol Appl Pharmacol 354:126–135
Linney E, Upchurch L, Donerly S (2004) Zebrafish as a neurotoxicological model. Neurotoxicol Teratol 26:709–718. https://doi.org/10.1016/j.ntt.2004.06.015
DeMicco A, Cooper KR, Richardson JR, White LA (2010) Developmental neurotoxicity of pyrethroid insecticides in zebrafish embryos. Toxicol Sci 113:177–186. https://doi.org/10.1093/toxsci/kfp258
Frank DF, Miller GW, Harvey DJ, Brander SM, Geist J, Connon RE et al (2018) Bifenthrin causes transcriptomic alterations in mTOR and ryanodine receptor-dependent signaling and delayed hyperactivity in developing zebrafish (Danio rerio). Aquat Toxicol 200:50–61. https://doi.org/10.1016/j.aquatox.2018.04.003
Kung TS, Richardson JR, Cooper KR, White LA (2015) Developmental deltamethrin exposure causes persistent changes in dopaminergic gene expression, neurochemistry, and locomotor activity in zebrafish. Toxicol Sci 146:235–243. https://doi.org/10.1093/toxsci/kfv087
Abreu-Villaca Y, Levin ED (2017) Developmental neurotoxicity of succeeding generations of insecticides. Environ Int 99:55–77. https://doi.org/10.1016/j.envint.2016.11.019
Selderslaghs IW, Hooyberghs J, De Coen W, Witters HE (2010) Locomotor activity in zebrafish embryos: a new method to assess developmental neurotoxicity. Neurotoxicol Teratol 32:460–471. https://doi.org/10.1016/j.ntt.2010.03.002
Tufi S, Leonards P, Lamoree M, de Boer J, Legler J, Legradi J (2016) Changes in neurotransmitter profiles during early zebrafish (Danio rerio) development and after pesticide exposure. Environ Sci Technol 50:3222–3230. https://doi.org/10.1021/acs.est.5b05665
Zhang X, Gong Z (2013) Fluorescent transgenic zebrafish Tg(nkx2.2a:mEGFP) provides a highly sensitive monitoring tool for neurotoxins. PLoS One 8:e55474. https://doi.org/10.1371/journal.pone.0055474
Sandstrom J, Eggermann E, Charvet I, Roux A, Toni N, Greggio C, Broyer A, Monnet-Tschudi F, Stoppini L (2017) Development and characterization of a human embryonic stem cell-derived 3D neural tissue model for neurotoxicity testing. Toxicol Vitro 38:124–135. https://doi.org/10.1016/j.tiv.2016.10.001
Tukker AM, de Groot MW, Wijnolts FM, Kasteel EE, Hondebrink L, Westerink RH (2016) Is the time right for in vitro neurotoxicity testing using human iPSC-derived neurons? Altex 33:261–271. https://doi.org/10.14573/altex.1510091
Tukker AM, Wijnolts FMJ, de Groot A, Westerink RHS (2018) Human iPSC-derived neuronal models for in vitro neurotoxicity assessment. Neurotoxicology 67:215–225. https://doi.org/10.1016/j.neuro.2018.06.007
Yamada S, Kubo Y, Yamazaki D, Sekino Y, Kanda Y (2017) Chlorpyrifos inhibits neural induction via Mfn1-mediated mitochondrial dysfunction in human induced pluripotent stem cells. Sci Rep 7:40925. https://doi.org/10.1038/srep40925
Wu X, Yang X, Majumder A, Swetenburg R, Goodfellow FT, Bartlett MG et al (2017) From the cover: astrocytes are protective against chlorpyrifos developmental neurotoxicity in human pluripotent stem cell-derived astrocyte-neuron cocultures. Toxicol Sci 157:410–420. https://doi.org/10.1093/toxsci/kfx056
Efremova L, Schildknecht S, Adam M, Pape R, Gutbier S, Hanf B et al (2015) Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism. Br J Pharmacol 172:4119–4132. https://doi.org/10.1111/bph.13193
Ishii MN, Yamamoto K, Shoji M, Asami A, Kawamata Y (2017) Human induced pluripotent stem cell (hiPSC)-derived neurons respond to convulsant drugs when co-cultured with hiPSC-derived astrocytes. Toxicology 389:130–138. https://doi.org/10.1016/j.tox.2017.06.010
Kuijlaars J, Oyelami T, Diels A, Rohrbacher J, Versweyveld S, Meneghello G et al (2016) Sustained synchronized neuronal network activity in a human astrocyte co-culture system. Sci Rep 6:36529. https://doi.org/10.1038/srep36529
Hoelting L, Klima S, Karreman C, Grinberg M, Meisig J, Henry M et al (2016) Stem cell-derived immature human dorsal root ganglia neurons to identify peripheral neurotoxicants. Stem Cells Transl Med 5:476–487. https://doi.org/10.5966/sctm.2015-0108
Neely MD, Davison CA, Aschner M, Bowman AB (2017) From the cover: manganese and rotenone-induced oxidative stress signatures differ in iPSC-derived human dopamine neurons. Toxicol Sci 159:366–379. https://doi.org/10.1093/toxsci/kfx145
Pistollato F, Canovas-Jorda D, Zagoura D, Bal-Price A (2017) Nrf2 pathway activation upon rotenone treatment in human iPSC-derived neural stem cells undergoing differentiation towards neurons and astrocytes. Neurochem Int 108:457–471. https://doi.org/10.1016/j.neuint.2017.06.006
Cam M, Durieu E, Bodin M, Manousopoulou A, Koslowski S, Vasylieva N et al (2018) Induction of Amyloid-beta42 production by fipronil and other pyrazole insecticides. J Alzheimers Dis 62:1663–1681. https://doi.org/10.3233/JAD-170875
Horton MK, Margolis AE, Tang C, Wright R (2014) Neuroimaging is a novel tool to understand the impact of environmental chemicals on neurodevelopment. Curr Opin Pediatr 26:230–236. https://doi.org/10.1097/MOP.0000000000000074
Acknowledgements
JRR was supported by National Institutes of Health Grants R01ES021800, R01ES026057, U01NS108956, and U01NS079249. VF was supported by R15ES027998. AGK was supported by National Institutes of Health R01 Grants ES027245, NS088206, ES026892, and NS10090. The Eugene and Linda Lloyd Endowed Chair and Eminent Scholar and Armbrust Endowment support to AGK are also acknowledged. He also thanks Drs. Adhithiya Charlie, Huajun Jin, and Mr. Gary Zenitsky for their assistance in preparing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Richardson, J.R., Fitsanakis, V., Westerink, R.H.S. et al. Neurotoxicity of pesticides. Acta Neuropathol 138, 343–362 (2019). https://doi.org/10.1007/s00401-019-02033-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-019-02033-9